Document:

EX-10.1

  Exhibit 10.1

  EXECUTIVE EMPLOYMENT AGREEMENT

  This EXECUTIVE EMPLOYMENT AGREEMENT (this “Agreement”) is entered into as of the 1st day of December, 2022 (the “Execution Date”), between STEVE M. SABUS (“Executive”) and Syndax Pharmaceuticals, Inc. (the “Company”).  Certain capitalized terms used in this Agreement are defined in Article 7.

  RECITALS

  A.The Company is a biopharmaceutical company.

  B.The Company desires to employ Executive in the position set forth below, and Executive wishes to be employed by the Company in such position, upon the terms and conditions set forth in this Agreement.

  AGREEMENT

  	NOW, THEREFORE, in consideration of the mutual promises contained herein, the Company and Executive agree as follows:

  Article 1

PRELIMINARY MATTERS

  1.1Effectiveness of Agreement.  This Agreement shall be effective on the Execution Date.

  Article 2

TERMS OF EMPLOYMENT

  2.1Appointment.  Executive’s start date with the Company is December 5, 2022 or such other date as mutually agreed upon by the Company and Executive (the “Start Date”).  Executive shall serve as Chief Commercial Officer, reporting to the Chief Executive Officer.  As Chief Commercial Officer, Executive will have such duties and responsibilities typically associated with such officer plus other reasonable duties as may from time to time be assigned to Executive.  During Executive’s employment with the Company, Executive shall (i) devote substantially all of Executive’s business efforts to the Company, and may (a) participate in charitable, civic, educational, professional, community or industry affairs, and (b) serve as a board member, advisor or a similar position, of up to two other companies, so long as such service does not conflict with or is not detrimental to the Company’s best interests, as determined in good faith by the Board, and (ii) faithfully and to the best of Executive’s abilities and experience, and in accordance with the standards and ethics of the business in which the Company is engaged, perform all duties that may be required of Executive by this Agreement, the Company’s policies and procedures, and such other duties and responsibilities as may be assigned to Executive from time to time, as well as the directives of the Board.  During Executive’s employment with the Company, Executive shall not engage in any activity that conflicts with or is detrimental to the Company’s best interests, as determined by the Board.  Executive and the Company acknowledge that Executive’s primary office will be remotely located, but that Executive will be required to spend a certain amount of time each month at the Company’s Waltham, MA headquarters and/or the Company’s New York, NY office.

  2.2Employment Term.  Executive will be employed by the Company on an “at-will” basis.  This means that either the Company or Executive may terminate Executive’s employment at any time, for any reason, with or without Cause, and with or without advance notice (provided that Resignation for Good 

  1

  

  Reason (as defined below) requires certain advanced notice by Executive.  It also means that Executive’s job title, duties, responsibilities, reporting level, compensation and benefits, as well as the Company’s personnel policies and procedures, may be changed with or without notice at any time in the Company’s sole discretion.  This at-will employment relationship shall not be modified by any conflicting actions or representations of any Company employee or other party before or during the term of Executive’s employment.

  2.3Compensation.

  a)Annual Base Salary.  Executive’s annual base salary shall be $495,000 per year (“Annual Base Salary”), payable in equal installments, less applicable deductions and withholdings, in accordance with the Company’s standard payroll practices.  Executive’s Annual Base Salary shall be subject to review by the Company’s compensation committee and may be increased or decreased from time to time, but shall not be reduced unless, and only to the extent that, the base salaries of all other similarly situated executives of the Company are proportionately reduced.

  b)Benefits.  Executive will be entitled to participate in all of the employee benefits and benefit plans that the Company generally makes available to its full-time employees and executives and for which Executive is eligible in accordance with the Company’s policies as in effect from time to time.  These benefits are subject to the terms, conditions, and eligibility requirements that govern or apply to them.

  c)Bonus.  In addition to Annual Base Salary, Executive shall be eligible to earn an annual performance bonus of up to forty percent (40%) of Executive’s Annual Base Salary, which bonus shall be earned upon Executive’s attainment of objectives to be determined by the Board (or the compensation committee thereof, as such determination may be delegated by the Board to the compensation committee) and continued employment with the Company as described below (the “Target Performance Bonus”).  The amount of and Executive’s eligibility for the Target Performance Bonus shall be determined in the sole discretion of the Board (or the compensation committee thereof, as such determination may be delegated by the Board to the compensation committee).  If earned, any Target Performance Bonus shall be paid to Executive, less authorized deductions and applicable withholdings, on or before the February 15th following the applicable bonus year.  For the 2022 calendar year, Executive will not be eligible to receive a Target Performance Bonus.  Except as provided in Sections 3.2 and 4.2, Executive shall be eligible to earn the Target Performance Bonus only if Executive is actively employed and in good standing with the Company on both the determination and payment dates for the Target Performance Bonus.  

  2.4Reimbursement of Expenses.  Subject to Section 5.10(c), the Company shall reimburse Executive for Executive’s necessary and reasonable business expenses incurred in connection with Executive’s duties in accordance with the Company’s generally applicable policies.

  2.5Grant of Stock Option.  As an inducement to Executive’s employment with the Company and subject to the approval of the Board or the compensation committee of the Board, approximately upon the Start Date Executive will be issued a non-qualified stock option to purchase 220,000 shares of the Company’s common stock (the “Option”).  The Option will be evidenced by and subject to the terms of an inducement stock option agreement (the “Inducement Award”).  Subject to the terms and conditions of the Inducement Award, the Option will have a term of ten (10) years from the Option’s grant date.  The exercise price per share of the Option will be equal to the per share fair market value of the Company’s common stock on the date the Option is granted, as determined by the Board.  The vesting schedule of the Option will be as follows:  twenty-five percent (25%) of the shares of the Company’s common stock subject to the Option will vest upon the one year anniversary of the Start Date, and one thirty-sixth (1/36th) of the remaining shares of the Company’s common stock subject to the Option will vest each month thereafter on 

  2

  

  the last day of each month, so long as Executive remains an employee, consultant, director or officer of the Company, and subject to the terms and conditions of the Inducement Award.

  Article 3

CHANGE IN CONTROL SEVERANCE BENEFITS

  3.1	Severance Benefits.  Upon a Change in Control Termination, and subject to the limitations and conditions set forth in this Agreement, Executive shall be eligible to receive the benefits set forth in this Article 3.  The receipt of any severance payments or benefits pursuant to this Agreement is subject to Executive signing and not revoking a separation agreement and general release of claims (the “Release”), in substantially the form attached hereto and incorporated herein as Exhibit A, Exhibit B or Exhibit C, as appropriate, which Release must become effective and irrevocable no later than the sixtieth (60th) day following Executive’s termination of employment (the “Release Deadline Date”).  If the Release does not become effective and irrevocable by the Release Deadline Date, Executive will forfeit any right to any severance payments or benefits under this Agreement.  In no event will severance payments or benefits be paid or provided until the Release actually becomes effective and irrevocable

  3.2Salary and Pro-Rata Bonus Payment.  In consideration of Executive’s execution and non-revocation of the Release by the Release Deadline Date in a form provided by the Company and in accordance with Article 4, the Company shall pay Executive a severance payment equal to (a) the sum of Executive’s Monthly Base Salary and Pro-Rata Bonus multiplied by (b) the number of months in the Change in Control Severance Period, less applicable withholdings.  The severance payment shall be payable (except as set forth in Article 5) in a lump sum on the first regularly-scheduled payroll date occurring on or after the Release Deadline Date. 

  3.3Health Continuation Coverage.

  a)Provided that Executive is eligible and has made the necessary elections for continuation coverage pursuant to COBRA under a health, dental or vision plan sponsored by the Company, the Company shall pay the applicable premiums (inclusive of premiums for Executive’s dependents for such health, dental or vision plan coverage as in effect immediately prior to the date of the Change in Control Termination) for such continued health, dental or vision plan coverage following the date of the Change in Control Termination for up to the number of months equal to the Change in Control Benefits Period (but in no event after such time as Executive is eligible for coverage under a health, dental or vision insurance plan of a subsequent employer or as Executive and Executive’s dependents are no longer eligible for COBRA coverage); provided that if continued payment by the Company of the applicable premiums would result in a violation of the nondiscrimination rules of Section 105(h)(2) of the Internal Revenue Code of 1986, as amended, or any statute or regulation of similar effect (including, without limitation, the 2010 Patient Protection and Affordable Care Act, as amended by the 2010 Health Care and Education Reconciliation Act), then in lieu of providing such continued payment, the Company will instead pay Executive on the first day of each month a fully taxable cash payment equal to the applicable premiums for that month, subject to applicable tax withholdings, for the remainder of the Change in Control Benefits Period.  Such coverage shall be counted as coverage pursuant to COBRA.  The Company shall have no obligation in respect of any premium payments (or any other payments in respect of health, dental or vision coverage from the Company) following the effective date of Executive’s coverage by a health, dental or vision insurance plan of a subsequent employer.  Executive shall be required to notify the Company immediately if Executive becomes covered by a health, dental or vision insurance plan of a subsequent employer.  If Executive and Executive’s dependents continue coverage pursuant to COBRA following the conclusion of the Change in Control Benefits Period, Executive will be responsible for the entire payment of such premiums required under COBRA for the duration of the COBRA period.

  3

  

  b)For purposes of this Section 3.3, (i) references to COBRA shall be deemed to refer also to analogous provisions of state law, and (ii) any applicable insurance premiums that are paid by the Company shall not include any amounts payable by Executive under a Code Section 125 health care reimbursement plan, which amounts, if any, are the sole responsibility of Executive. 

  3.4Stock Awards.  Upon a Change in Control Termination, (a) the vesting and exercisability of all outstanding options to purchase the Company’s common stock (or stock appreciation rights or other rights with respect to the stock of the Company issued pursuant to any equity incentive plan of the Company) that are held by Executive on the Termination Date shall be accelerated in full, (b) any reacquisition or repurchase rights held by the Company with respect to common stock issued or issuable (or with respect to other rights with respect to the stock of the Company issued or issuable) pursuant to any other stock award granted to Executive pursuant to any equity incentive plan of the Company shall lapse and (c) the time period that Executive has to exercise any outstanding options to purchase the Company’s common stock that are held by Executive on the Termination Date shall be extended for a period equal to the shorter of (i) twelve (12) months or (ii) the remaining term of the outstanding option.

  Article 4

COVERED TERMINATION SEVERANCE BENEFITS

  4.1Severance Benefits.  Upon a Covered Termination, and subject to the limitations and conditions set forth in this Agreement, Executive shall be eligible to receive the benefits set forth in this Article 4.  The receipt of any severance payments or benefits pursuant to this Agreement is subject to Executive signing and not revoking the appropriate Release, which Release must become effective and irrevocable no later than the Release Deadline Date.  If the Release does not become effective and irrevocable by the Release Deadline Date, Executive will forfeit any right to any severance payments or benefits under this Agreement.  In no event will severance payments or benefits be paid or provided until the Release actually becomes effective and irrevocable. 

  4.2Salary Payment.  In consideration of Executive’s timely execution and non-revocation of the Release by the Release Deadline Date, the Company shall pay Executive a severance payment equal to Executive’s Monthly Base Salary multiplied by the number of months in the Covered Termination Severance Period, less applicable withholdings.  The severance payment shall be payable (except as set forth in Article 5) in a lump sum on the first regularly-scheduled payroll date occurring on or after the Release Deadline Date.

  4.3Health Continuation Coverage.

  a)Provided that Executive is eligible and has made the necessary elections for continuation coverage pursuant to COBRA under a health, dental or vision plan sponsored by the Company, the Company shall pay for the applicable premiums (inclusive of premiums for Executive’s dependents for such health, dental or vision plan coverage as in effect immediately prior to the date of the Covered Termination) for such continued health, dental or vision plan coverage following the date of the Covered Termination for up to the number of months equal to the Covered Termination Benefits Period (but in no event after such time as Executive is eligible for coverage under a health, dental or vision insurance plan of a subsequent employer or as Executive and Executive’s dependents are no longer eligible for COBRA coverage); provided that if continued payment by the Company of the applicable premiums would result in a violation of the nondiscrimination rules of Section 105(h)(2) of the Internal Revenue Code of 1986, as amended, or any statute or regulation of similar effect (including, without limitation, the 2010 Patient Protection and Affordable Care Act, as amended by the 2010 Health Care and Education Reconciliation Act), then in lieu of providing such continued payment, the Company will instead pay Executive on the 

  4

  

  first day of each month a fully taxable cash payment equal to the applicable premiums for that month, subject to applicable tax withholdings, for the remainder of the Covered Termination Benefits Period.  Such coverage shall be counted as coverage pursuant to COBRA.  The Company shall have no obligation in respect of any premium payments (or any other payments in respect of health, dental or vision coverage from the Company) following the effective date of Executive’s coverage by a health, dental or vision insurance plan of a subsequent employer.  Executive shall be required to notify the Company immediately if Executive becomes covered by a health, dental or vision insurance plan of a subsequent employer.  If Executive and Executive’s dependents continue coverage pursuant to COBRA following the conclusion of the Covered Termination Benefits Period, Executive will be responsible for the entire payment of such premiums required under COBRA for the duration of the COBRA period.

  b)For purposes of this Section 4.3, (i) references to COBRA shall be deemed to refer also to analogous provisions of state law, and (ii) any applicable insurance premiums that are paid by the Company shall not include any amounts payable by Executive under a Code Section 125 health care reimbursement plan, which amounts, if any, are the sole responsibility of Executive.

  4.4Stock Awards.  Upon a Covered Termination:

  a)the vesting and exercisability of all outstanding options to purchase the Company’s common stock (or stock appreciation rights or other rights with respect to the stock of the Company issued pursuant to any equity incentive plan of the Company) that are held by Executive on the Termination Date shall be accelerated as to the number of shares of common stock issuable upon exercise of such option (“Option Shares”) as equals the number of Option Shares as would otherwise vest during the twelve (12) month period following the Termination Date in accordance with the applicable options’ vesting schedule were the Executive to remain an employee of the Company during such twelve (12) month period (disregarding any other basis for acceleration of vesting of Option Shares during such twelve (12) month period);

  b)any reacquisition or repurchase rights held by the Company with respect to common stock issued or issuable (or with respect to other rights with respect to the stock of the Company issued or issuable) pursuant to any option to purchase the Company’s common stock (or stock appreciation rights or other rights with respect to the stock of the Company) (“Restricted Shares”) held by the Executive as of the Termination Date shall lapse as to the number of Restricted Shares as equals the number of Restricted Shares as to which such reacquisition or repurchase rights would otherwise lapse during the twelve (12) month period following the Termination Date in accordance with the option’s vesting schedule were the Executive to remain an employee of the Company during such twelve (12) month period (disregarding any other basis for acceleration of the lapsing of such reacquisition or repurchase rights on Restricted Shares during such twelve (12) month period); and

  c)the time period that Executive has to exercise any outstanding options to purchase the Company’s common stock that are held by Executive on the Termination Date shall be extended for a period equal to the shorter of (i) twelve (12) months or (ii) the remaining term of the outstanding option.

  Article 5

LIMITATIONS AND CONDITIONS ON BENEFITS

  5.1Rights Conditioned on Compliance.  Executive’s rights to receive all severance benefits described in Article 3 and Article 4 shall be conditioned upon and subject to Executive’s compliance with the limitations and conditions on benefits as described in this Article 5.

  5

  

  5.2Continuation of Service Until Date of Termination.  Executive shall continue to provide service to the Company in good faith until the Termination Date, unless such performance is otherwise excused in writing by the Company.

  5.3Release Prior to Payment of Benefits.  Upon the occurrence of a Change in Control Termination or a Covered Termination, as applicable, and prior to Executive earning any entitlement to any severance or separation benefits under this Agreement on account of such Change in Control Termination or Covered Termination, as applicable, Executive must execute the appropriate Release, and such Release must become effective in accordance with its terms, but in no event later than the Release Deadline Date.  No amount shall be paid prior to such date.  Instead, on the first regularly-scheduled payroll date occurring on or after the Release Deadline Date, the Company will pay Executive the severance amount that Executive would otherwise have received on or prior to such date but for the delay in payment related to the effectiveness of the Release, with the balance of the severance amount being paid as originally scheduled.  The Company may modify the Release in its discretion to comply with changes in applicable law at any time prior to Executive’s execution of such Release.  Such Release shall specifically relate to all of Executive’s rights and claims in existence at the time of such execution and shall confirm Executive’s obligations under the Confidentiality Agreement and any similar obligations under applicable law.  It is understood that, as specified in the applicable Release, Executive has a certain number of calendar days to consider whether to execute such Release.  If Executive does not execute and deliver such Release within the applicable period, no benefits shall be provided or payable under this Agreement, and Executive shall have no further rights, title or interests in or to any severance benefits or payments pursuant to this Agreement.  It is further understood that if Executive is age 40 or older at the time of a Change in Control Termination or a Covered Termination, as applicable, Executive may revoke the applicable Release within seven (7) calendar days after its execution by Executive.  If Executive revokes such Release within such subsequent seven (7) day period, no benefits shall be provided or payable under this Agreement pursuant to such Change in Control Termination or Covered Termination, as applicable.

  5.4Return of Company Property.  Not later than the Termination Date, Executive shall return to the Company all documents (and all copies thereof) and other property belonging to the Company that Executive has in his or her possession or control.  The documents and property to be returned include, but are not limited to, all files, correspondence, email, memoranda, notes, notebooks, records, plans, forecasts, reports, studies, analyses, compilations of data, proposals, agreements, financial information, research and development information, marketing information, operational and personnel information, databases, computer-recorded information, tangible property and equipment (including, but not limited to, computers, facsimile machines, mobile telephones and servers), credit cards, entry cards, identification badges and keys, and any materials of any kind which contain or embody any proprietary or confidential information of the Company (and all reproductions thereof in whole or in part).  Executive agrees to make a diligent search to locate any such documents, property and information.  If Executive has used any personally owned computer, server or e-mail system to receive, store, review, prepare or transmit any Company confidential or proprietary data, materials or information, then within ten (10) business days after the Termination Date, Executive shall provide the Company with a computer-useable copy of all such information and then permanently delete and expunge such confidential or proprietary information from those systems.  Executive agrees to provide the Company access to Executive’s system as requested to verify that the necessary copying and/or deletion is done.

  5.5Cooperation and Continued Compliance with Restrictive Covenants.

  a)From and after the Termination Date, Executive shall cooperate fully with the Company in connection with its actual or contemplated defense, prosecution or investigation of any existing or future litigation, arbitrations, mediations, claims, demands, audits, government or regulatory inquiries, or other matters arising from events, acts or failures to act that occurred during the time period in which 

  6

  

  Executive was employed by the Company (including any period of employment with an entity acquired by the Company).  Such cooperation includes, without limitation, being available upon reasonable notice, without subpoena, to provide accurate and complete advice, assistance and information to the Company, including offering and explaining evidence, providing truthful and accurate sworn statements, and participating in discovery and trial preparation and testimony.  Executive also agrees to promptly send the Company copies of all correspondence (for example, but not limited to, subpoenas) received by Executive in connection with any such legal proceedings, unless Executive is expressly prohibited by law from so doing.  The Company will reimburse Executive for reasonable out-of-pocket expenses incurred in connection with any such cooperation (excluding foregone wages, salary or other compensation) within thirty (30) days of Executive’s timely presentation of appropriate documentation thereof, in accordance with the Company’s standard reimbursement policies and procedures, and will make reasonable efforts to accommodate Executive’s scheduling needs.

  b)From and after the Termination Date, Executive shall continue to abide by all of the terms and provisions of the Confidentiality Agreement (and any other comparable agreement signed by Executive), in accordance with its terms. 

  c)Executive acknowledges and agrees that Executive’s obligations under this Section 5.5 are an essential part of the consideration Executive is providing hereunder in exchange for which and in reliance upon which the Company has agreed to provide the payments and benefits under this Agreement.  Executive further acknowledges and agrees that Executive’s violation of this Section 5.5 inevitably would involve use or disclosure of the Company’s proprietary and confidential information.  Accordingly, Executive agrees that Executive will forfeit, effective as of the date of any breach, any right, entitlement, claim or interest in or to any unpaid portion of the severance payments or benefits provided in Article 3 or Article 4.  If it is determined by a court of competent jurisdiction in any state that any restriction in this Section 5.5 is excessive in duration or scope or is unreasonable or unenforceable under the laws of that state, it is the intention of the parties that such restriction may be modified or amended by the court to render it enforceable to the maximum extent permitted by the law of that state.

  5.6Parachute Payments.

  a)Parachute Payment Limitation.  If any payment or benefit (including payments and benefits pursuant to this Agreement) Executive would receive in connection with a Change in Control from the Company or otherwise (“Payment”) would (i) constitute a “parachute payment” within the meaning of Section 280G of the Code, and (ii) but for this paragraph, be subject to the excise tax imposed by Section 4999 of the Code (the “Excise Tax”), then the Company shall cause to be determined, before any amounts of the Payment are paid to Executive, which of the following two alternative forms of payment shall be paid to Executive: (A) payment in full of the entire amount of the Payment (a “Full Payment”), or (B) payment of only a part of the Payment so that Executive receives the largest payment possible without the imposition of the Excise Tax (a “Reduced Payment”).  A Full Payment shall be made in the event that the amount received by Executive on a net after-tax basis is greater than what would be received by Executive on a net after-tax basis if the Reduced Payment were made, otherwise a Reduced Payment shall be made.  If a Reduced Payment is made, (i) the Payment shall be paid only to the extent permitted under the Reduced Payment alternative, and Executive shall have no rights to any additional payments and/or benefits constituting the Payment, and (ii) reduction in payments and/or benefits shall occur in the following order: (A) reduction of cash payments; (B) cancellation of accelerated vesting of equity awards other than stock options; (C) cancellation of accelerated vesting of stock options; and (D) reduction of other benefits paid to Executive.  In the event that acceleration of compensation from Executive’s equity awards is to be reduced, such acceleration of vesting shall be canceled in the reverse order of the date of grant.

  7

  

  b)The independent registered public accounting firm engaged by the Company for general audit purposes as of the day prior to the effective date of the Change in Control shall make all determinations required to be made under this Section 5.6.  If the independent registered public accounting firm so engaged by the Company is serving as accountant or auditor for the individual, entity or group effecting the Change in Control, the Company shall appoint a nationally recognized independent registered public accounting firm to make the determinations required hereunder.  The Company shall bear all expenses with respect to the determinations by such independent registered public accounting firm required to be made hereunder.

  c)The independent registered public accounting firm engaged to make the determinations hereunder shall provide its calculations, together with detailed supporting documentation, to the Company and Executive within fifteen (15) calendar days after the date on which Executive’s right to a Payment is triggered (if requested at that time by the Company or Executive) or such other time as requested by the Company or Executive.  If the independent registered public accounting firm determines that no Excise Tax is payable with respect to a Payment, either before or after the application of the Reduced Amount, it shall furnish the Company and Executive with an opinion reasonably acceptable to Executive that no Excise Tax will be imposed with respect to such Payment.  Any good faith determinations of the accounting firm made hereunder shall be final, binding and conclusive upon the Company and Executive. 

  5.7Certain Reductions and Offsets.  To the extent that any federal, state or local laws, including, without limitation, the Worker Adjustment and Retraining Notification Act or any other so-called “plant closing” laws, require the Company to give advance notice or make a payment of any kind to Executive because of Executive’s involuntary termination due to a layoff, reduction in force, plant or facility closing, sale of business, change in control or any other similar event or reason, the benefits payable under this Agreement shall be correspondingly reduced.  The benefits provided under this Agreement are intended to satisfy any and all statutory obligations that may arise out of Executive’s involuntary termination of employment for the foregoing reasons, and the parties shall construe and enforce the terms of this Agreement accordingly.

  5.8Mitigation.  Except as otherwise specifically provided herein, Executive shall not be required to mitigate damages or the amount of any payment provided under this Agreement by seeking other employment or otherwise, nor shall the amount of any payment provided for under this Agreement be reduced by any compensation earned by Executive as a result of employment by another employer or by any retirement benefits received by Executive after the date of a Change in Control Termination or Covered Termination (except as expressly provided in Sections 3.3 and 4.3 above). 

  5.9Indebtedness of Executive.  If Executive is indebted to the Company on the effective date of a Change in Control Termination or Covered Termination, the Company reserves the right to offset any severance payments and benefits under this Agreement by the amount of such indebtedness. 

  5.10Application of Section 409A.

  a)Separation from Service.  Notwithstanding any provision to the contrary in this Agreement, no amount deemed deferred compensation subject to Section 409A of the Code shall be payable pursuant to Article 3 or Article 4 unless Executive’s termination of employment constitutes a “separation from service” with the Company within the meaning of Section 409A of the Code and the Department of Treasury Regulations and other guidance promulgated thereunder and, except as provided under Section 5.10(b) hereof, any such amount shall not be paid, or in the case of installments, commence payment, until the first regularly-scheduled payroll date occurring on or after the sixtieth (60th) day following Executive’s separation from service.  Any installment payments that would have been made to Executive during the sixty (60) day period immediately following Executive’s separation from service but for the preceding 

  8

  

  sentence shall be paid to Executive on the first regularly-scheduled payroll date occurring on or after the sixtieth (60th) day after Executive’s separation from service and the remaining payments shall be made as provided in this Agreement.

  b)Specified Executive.  Notwithstanding any provision to the contrary in this Agreement, if Executive is deemed at the time of his or her separation from service to be a “specified employee” for purposes of Section 409A(a)(2)(B)(i) of the Code, to the extent delayed commencement of any portion of the benefits to which Executive is entitled under this Agreement is required in order to avoid a prohibited distribution under Section 409A(a)(2)(B)(i) of the Code, such portion of Executive’s benefits shall not be provided to Executive prior to the earlier of (i) the expiration of the six (6)-month period measured from the date of Executive’s “separation from service” with the Company (as such term is defined in the Treasury Regulations issued under Section 409A of the Code) or (ii) the date of Executive’s death.  Upon the first business day following the expiration of the applicable Code Section 409A(a)(2)(B)(i) period, all payments deferred pursuant to this Section 5.10(b) shall be paid in a lump sum to Executive, and any remaining payments due under this Agreement shall be paid as otherwise provided herein.

  c)Expense Reimbursements.  To the extent that any reimbursement payable pursuant to this Agreement is subject to the provisions of Section 409A of the Code, any such reimbursement payable to Executive pursuant to this Agreement shall be paid to Executive no later than December 31 of the year following the year in which the expense was incurred; the amount of expenses reimbursed in one year shall not affect the amount eligible for reimbursement in any subsequent year; and Executive’s right to reimbursement under this Agreement will not be subject to liquidation or exchange for another benefit.

  d)Installments.  For purposes of Section 409A of the Code (including, without limitation, for purposes of Treasury Regulation Section 1.409A-2(b)(2)(iii)), Executive’s right to receive any installment payments under this Agreement shall be treated as a right to receive a series of separate payments and, accordingly, each such installment payment shall at all times be considered a separate and distinct payment.

  5.11Tax Withholding.  All payments under this Agreement shall be subject to applicable withholding for federal, state and local income and employment taxes. 

  5.12No Duplication of Severance Benefits.  The severance and other benefits provided in Article 3 and Article 4 are mutually exclusive of each other, and in no event shall Executive receive any severance or other benefits pursuant to both Article 3 and Article 4.

  Article 6

TERMINATION WITH CAUSE OR BY VOLUNTARY RESIGNATION; 

  OTHER RIGHTS AND BENEFITS

  6.1Termination for Cause by the Company.  If the Company shall terminate the Executive’s employment with the Company for Cause, then upon such termination, the Company shall have no further obligation to Executive hereunder except for the payment or provision, as applicable, of (a) the portion of the Annual Base Salary for the period prior to the effective date of termination earned but unpaid (if any), (b) all unreimbursed expenses (if any), subject to Sections 2.4 and 5.10(c), and (c) other payments, entitlements or benefits, if any, in accordance with terms of the applicable plans, programs, arrangements or other agreements of the Company (other than any severance plan or policy) as to which the Executive held rights to such payments, entitlements or benefits, whether as a participant, beneficiary or otherwise on the date of termination (“Other Benefits”).  For the avoidance of doubt, Executive shall have no right to 

  9

  

  receive (and Other Benefits shall not include) any amounts under any Company severance plan or policy or pursuant to Article 3 or Article 4 upon Executive’s termination for Cause.  

  6.2Termination by Voluntary Resignation by the Executive (other than Resignation for Good Reason).  Upon any voluntary resignation by Executive that is not a Resignation for Good Reason, the Company shall have no further obligation to the Executive hereunder except for the payment of (a) the portion of the Annual Base Salary for the period prior to the effective date of termination earned but unpaid (if any), (b) all unreimbursed expenses (if any), subject to Sections 2.4 and 5.10(c), and (c) the payment or provision of any Other Benefits.  For the avoidance of doubt, Executive shall have no right to receive (and Other Benefits shall not include) any amounts under any Company severance plan or policy or pursuant to Article 3 or Article 4 upon any voluntary resignation by Executive that is not a Resignation for Good Reason.  

  6.3Other Rights and Benefits.  Nothing in this Agreement shall prevent or limit Executive’s continuing or future participation in any benefit, bonus, incentive or other plans, programs, policies or practices provided by the Company and for which Executive may otherwise qualify, nor shall anything herein limit or otherwise affect such rights as Executive may have under other agreements with the Company except as provided in Article 2, Article 5, Section 6.1 and Section 6.2 above.  Except as otherwise expressly provided herein, amounts that are vested benefits or that Executive is otherwise entitled to receive under any plan, policy, practice or program of the Company at or subsequent to the date of a Change in Control shall be payable in accordance with such plan, policy, practice or program. 

  Article 7

DEFINITIONS

  Unless otherwise provided, for purposes of this Agreement, the following definitions shall apply: 

  7.1“Board” means the Board of Directors of the Company.

  7.2“Cause” means, upon a reasonable determination by the Company, Executive’s: (a) dishonest statements or acts with respect to the Company, any subsidiary or any affiliate of the Company or any subsidiary; (b) commission by or indictment for (i) a felony or (ii) any misdemeanor (excluding minor traffic violations) involving moral turpitude, deceit, dishonesty or fraud (“indictment,” for these purposes, meaning an indictment, probable cause hearing or any other procedure pursuant to which an initial determination of probable or reasonable cause with respect to such offense is made); (c) gross negligence, willful misconduct or insubordination with respect to the Company, any subsidiary or any affiliate of the Company or any subsidiary; (d) material breach of any of Executive’s obligations under any agreement to which Executive and the Company or any subsidiary are a party; or (e) death or disability.  With respect to clause (d), Executive will be given notice and a 30-day period in which to cure such breach, only to the extent such breach can be reasonably expected to be able to be cured within such period.  Executive agrees that the breach of any confidentiality obligation to the Company or any subsidiary shall not be curable to any extent.

  7.3“Change in Control” means the occurrence, in a single transaction or in a series of related transactions, of any one or more of the following events:

  a)Any natural person, entity or group within the meaning of Section 13(d) or 14(d) of the Securities Exchange Act of 1934, as amended (“Exchange Act Person”), becomes the owner, directly or indirectly, of securities of the Company representing more than fifty percent (50%) of the combined voting power of the Company’s then outstanding securities other than by virtue of a merger, consolidation 

  10

  

  or similar transaction.  Notwithstanding the foregoing, a Change in Control shall not be deemed to occur (i) on account of the acquisition of securities of the Company by any institutional investor, any affiliate thereof or any other Exchange Act Person that acquires the Company’s securities in a transaction or series of related transactions that are primarily a private financing transaction for the Company or (ii) solely because the level of ownership held by any Exchange Act Person (the “Subject Person”) exceeds the designated percentage threshold of the outstanding voting securities as a result of a repurchase or other acquisition of voting securities by the Company reducing the number of shares outstanding, provided that if a Change in Control would occur (but for the operation of this sentence) as a result of the acquisition of voting securities by the Company, and after such share acquisition, the Subject Person becomes the owner of any additional voting securities that, assuming the repurchase or other acquisition had not occurred, increases the percentage of the then outstanding voting securities owned by the Subject Person over the designated percentage threshold, then a Change in Control shall be deemed to occur;

  b)There is consummated a merger, consolidation or similar transaction involving, directly or indirectly, the Company if, immediately after the consummation of such merger, consolidation or similar transaction, the stockholders of the Company immediately prior thereto do not own, directly or indirectly, either (i) outstanding voting securities representing more than fifty percent (50%) of the combined outstanding voting power of the surviving entity in such merger, consolidation or similar transaction or (ii) more than fifty percent (50%) of the combined outstanding voting power of the parent of the surviving entity in such merger, consolidation or similar transaction;

  c)The stockholders of the Company approve or the Board approves a plan of complete dissolution or liquidation of the Company, or a complete dissolution or liquidation of the Company shall otherwise occur; or

  d)There is consummated a sale, lease, license or other disposition of all or substantially all of the consolidated assets of the Company and its subsidiaries, other than a sale, lease, license or other disposition of all or substantially all of the consolidated assets of the Company and its subsidiaries to an entity, more than fifty percent (50%) of the combined voting power of the voting securities of which are owned by stockholders of the Company in substantially the same proportion as their ownership of the Company immediately prior to such sale, lease, license or other disposition. 

  The term Change in Control shall not include a sale of assets, merger or other transaction effected exclusively for the purpose of changing the domicile of the Company.  Notwithstanding the foregoing or any other provision of this Agreement, the definition of Change in Control (or any analogous term) in an individual written agreement between the Company or any affiliate and the participant shall supersede the foregoing definition with respect to stock awards subject to such agreement (it being understood, however, that if no definition of Change in Control or any analogous term is set forth in such an individual written agreement, the foregoing definition shall apply). 

  7.4“Change in Control Benefits Period” means the period of twelve (12) months commencing on the Termination Date.

  7.5“Change in Control Severance Period” means the period of twelve (12) months commencing on the Termination Date.

  7.6“Change in Control Termination” means an “Involuntary Termination Without Cause” or “Resignation for Good Reason,” either of which occurs on, or within three (3) months prior to, or within twelve (12) months following, the effective date of a Change in Control, provided that any such termination is a “separation from service” within the meaning of Treasury Regulation Section 1.409A-1(h). Death and disability shall not be deemed Change in Control Terminations.

  11

  

  7.7“COBRA” means the Consolidated Omnibus Budget Reconciliation Act of 1985, as amended.

  7.8“Code” means the Internal Revenue Code of 1986, as amended.

  7.9“Company” means Syndax Pharmaceuticals, Inc. or, following a Change in Control, the surviving entity resulting from such transaction, or any subsequent surviving entity resulting from any subsequent Change in Control.

  7.10“Confidentiality Agreement” means Executive’s Assignment of Developments, Non-Disclosure, and Non-Solicitation Agreement with the Company (or any successor agreement thereto).

  7.11“Covered Termination” means an “Involuntary Termination Without Cause” or “Resignation for Good Reason,” provided that any such termination is a “separation from service” within the meaning of Treasury Regulation Section 1.409A-1(h).  Death and disability shall not be deemed Covered Terminations.  If an Involuntary Termination Without Cause or Resignation for Good Reason qualifies as a Change in Control Termination, it shall not constitute a Covered Termination.

  7.12“Covered Termination Benefits Period” means the period of nine (9) months commencing on the Termination Date.

  7.13“Covered Termination Severance Period” means the period of nine (9) months commencing on the Termination Date.

  7.14“Involuntary Termination Without Cause” means Executive’s dismissal or discharge by the Company for reasons other than Cause and other than as a result of death or disability.

  7.15“Monthly Base Salary” means 1/12th of the greater of (i) Executive’s annual base salary (excluding incentive pay, premium pay, commissions, overtime, bonuses and other forms of variable compensation) as in effect on the date of a Change in Control Termination or a Covered Termination, as applicable, or (ii) in the case of a Change in Control Termination, Executive’s annual base salary (excluding incentive pay, premium pay, commissions, overtime, bonuses and other forms of variable compensation) as in effect on the date of a Change in Control.

  7.16“Pro-Rata Bonus” means 1/12th of the greater of (i) the average Target Performance Bonus paid to Executive for the three years preceding the date of a Change in Control Termination (or such lesser number of years during which Executive has been employed by the Company), or (ii) the Target Performance Bonus, as in effect on the date of a Change in Control Termination.

  7.17“Resignation for Good Reason” means Executive’s resignation from all employee positions Executive then holds with the Company within sixty (60) days following any of the following events taken without Executive’s consent, provided Executive has given the Company written notice of such event within thirty (30) days after the first occurrence of such event and the Company has not cured such event within thirty (30) days thereafter:

  a)A decrease in Executive’s total target cash compensation (base and bonus) of more than 10% (i.e., a material reduction in Executive’s base compensation and a material breach by the Company of Executive’s employment terms with the Company), other than in connection with a comparable decrease in compensation for all comparable executives of the Company;

  12

  

  b)Executive’s duties or responsibilities are materially diminished (not simply a change in title or reporting relationships); provided, that Executive shall not be deemed to have a “Resignation for Good Reason” if the Company survives as a separate legal entity or business unit following the Change in Control and Executive holds materially the same position in such legal entity or business unit as Executive held before the Change in Control;

  c)Either (i) Executive is required to establish residence in a location more than fifty (50) miles from Executive’s current principal personal residence or (ii) there is an increase in Executive’s round-trip driving distance of more than fifty (50) miles from Executive’s current principal personal residence to the principal office or business location at which Executive is required to perform services (except for required business travel to the extent consistent with Executive’s prior business travel obligations) (“Executive’s Principal Place of Business”) as a result of a change in location by the Company of Executive’s Principal Place of Business; or

  d)The failure of the Company to obtain a satisfactory agreement from any successor to materially assume and materially agree to perform under the terms of this Agreement. 

  7.18“Termination Date” means the effective date of the Change in Control Termination, the Covered Termination or a termination for Cause, as applicable. 

  Article 8

GENERAL PROVISIONS

  8.1Employment Status.  This Agreement does not constitute a contract of employment or impose upon Executive any obligation to remain as an employee, or impose on the Company any obligation (i) to retain Executive as an employee, (ii) to change the status of Executive as an at-will employee or (iii) to change the Company’s policies regarding termination of employment.

  8.2Notices.  Any notices provided hereunder must be in writing, and such notices or any other written communication shall be deemed effective upon the earlier of personal delivery (including personal delivery by facsimile) or the third day after mailing by first class mail, to the Company at its primary office location and to Executive at Executive’s address as listed in the Company’s payroll records.  Any payments made by the Company to Executive under the terms of this Agreement shall be delivered to Executive either in person or at the address as listed in the Company’s payroll records.

  8.3Severability.  Whenever possible, each provision of this Agreement will be interpreted in such manner as to be effective and valid under applicable law, but if any provision of this Agreement is held to be invalid, illegal or unenforceable in any respect under any applicable law or rule in any jurisdiction, such invalidity, illegality or unenforceability will not affect any other provision or any other jurisdiction, but this Agreement will be reformed, construed and enforced in such jurisdiction as if such invalid, illegal or unenforceable provisions had never been contained herein. 

  8.4Waiver.  If either party should waive any breach of any provisions of this Agreement, he, she or it shall not thereby be deemed to have waived any preceding or succeeding breach of the same or any other provision of this Agreement. 

  8.5Complete Agreement.  This Agreement, including Exhibit A, Exhibit B and Exhibit C, and the Confidentiality Agreement constitute the entire agreement between Executive and the Company and is the complete, final and exclusive embodiment of their agreement with regard to this subject matter, wholly superseding all written and oral agreements with respect to payments and benefits to Executive in 

  13

  

  the event of employment termination.  It is entered into without reliance on any promise or representation other than those expressly contained herein. 

  8.6Amendment or Termination of Agreement; Continuation of Agreement.  This Agreement may be changed or terminated only upon the mutual written consent of the Company and Executive.  The written consent of the Company to a change or termination of this Agreement must be signed by an executive officer of the Company (other than Executive) after such change or termination has been approved by the Board.  Unless so terminated, this Agreement shall continue in effect for as long as Executive continues to be employed by the Company or by any surviving entity following any Change in Control.  In other words, if, following a Change in Control, Executive continues to be employed by the surviving entity without a Change in Control Termination and the surviving entity then undergoes a Change in Control, following which Executive is terminated by the subsequent surviving entity in a Change in Control Termination, then Executive shall receive the benefits described in Article 3 hereof.

  8.7Counterparts.  This Agreement may be executed in separate counterparts, any one of which need not contain signatures of more than one party, but all of which taken together will constitute one and the same Agreement.

  8.8Headings.  The headings of the Articles and Sections hereof are inserted for convenience only and shall not be deemed to constitute a part hereof nor to affect the meaning thereof.

  8.9Successors and Assigns.  This Agreement is intended to bind and inure to the benefit of and be enforceable by Executive, and the Company, and any surviving entity resulting from a Change in Control and upon any other person who is a successor by merger, acquisition, consolidation or otherwise to the business formerly carried on by the Company, and their respective successors, assigns, heirs, executors and administrators, without regard to whether or not such person actively assumes any rights or duties hereunder; provided, however, that Executive may not assign any duties hereunder and may not assign any rights hereunder without the written consent of the Company, which consent shall not be withheld unreasonably.

  8.10Choice of Law.  Because of the Company’s and Executive’s interests in ensuring that disputes regarding this Agreement are resolved on a uniform basis, the parties agree that all questions concerning the construction, validity and interpretation of this Agreement will be governed by the law of the State of New York, without regard for any conflict of law principles.  Further, the parties consent to the jurisdiction of the state and federal courts of the State of New York for all purposes in connection with this Agreement.  The parties hereby irrevocably waive, to the fullest extent permitted by applicable law, any objection which Executive or the Company may now or hereafter have to the laying of venue of any such dispute brought in such court or any defense of inconvenient forum for the maintenance of such dispute. 

  8.11Arbitration.  To ensure the rapid and economical resolution of any disputes that may arise under or relate to this Agreement or Executive’s employment relationship, Executive and the Company agree that any and all disputes, claims, or causes of action, in law or equity, arising from or relating to the performance, enforcement, execution, or interpretation of this Agreement, Executive’s employment with the Company, or the termination of Executive’s employment (collectively, “Claims”), shall be resolved to the fullest extent permitted by law, by final, binding, and (to the extent permitted by law) confidential arbitration before a single arbitrator in the state where Executive is employed.  The arbitration shall be governed by the Federal Arbitration Act, 9 U.S.C. Section 1 et seq., as amended, and shall be administered by the Judicial Arbitration & Mediation Services, Inc. (“JAMS”), in accordance with its then-current Employment Arbitration Rules & Procedures (the “JAMS Rules”).  The JAMS Rules are also available online at http://www.jamsadr.com/rules-employment-arbitration/.   The parties or their representatives may also call JAMS at 800.352.5267 if they have questions about the arbitration process.   If the JAMS Rules 

  14

  

  are inconsistent with the terms of this Agreement, the terms of this Agreement shall govern.  Notwithstanding the foregoing, this provision shall exclude Claims that by law are not subject to arbitration.  The arbitrator shall:  (a) have the authority to compel adequate discovery for the resolution of all Claims and to award such relief as would otherwise be permitted by law; and (b) issue a written arbitration decision including the arbitrator’s essential findings and conclusions and a statement of the award.  The Company shall pay all JAMS fees in excess of the amount of filing and other court-related fees Executive would have been required to pay if the Claims were asserted in a court of law.   EXECUTIVE AND THE COMPANY UNDERSTAND AND FULLY AGREE THAT BY ENTERING INTO THIS AGREEMENT, BOTH EXECUTIVE AND THE COMPANY ARE GIVING UP THE CONSTITUTIONAL RIGHT TO HAVE A TRIAL BY JURY, AND ARE GIVING UP THE NORMAL RIGHTS OF APPEAL FOLLOWING THE RENDERING OF A DECISION, EXCEPT AS THE FEDERAL ARBITRATION ACT AND APPLICABLE FEDERAL LAW ALLOW FOR JUDICIAL REVIEW OF ARBITRATION PROCEEDINGS.  Nothing in this Agreement shall prevent either Executive or the Company from obtaining injunctive relief in court to prevent irreparable harm pending the conclusion of any such arbitration.  Any awards or final orders in such arbitrations may be entered and enforced as judgments or orders in the federal and state courts of any competent jurisdiction in compliance with Section 8.11 of this Agreement.

  8.12Construction of Agreement.  In the event of a conflict between the text of this Agreement and any summary, description or other information regarding this Agreement, the text of this Agreement shall control.

  8.13Circular 230 Disclaimer.  THE FOLLOWING DISCLAIMER IS PROVIDED IN ACCORDANCE WITH THE INTERNAL REVENUE SERVICE’S CIRCULAR 230 (21 C.F.R. PART 10).  ANY TAX ADVICE CONTAINED IN THIS AGREEMENT IS INTENDED TO BE PRELIMINARY, FOR DISCUSSION PURPOSES ONLY AND NOT FINAL.  ANY SUCH ADVICE IS NOT INTENDED TO BE USED FOR MARKETING, PROMOTING OR RECOMMENDING ANY TRANSACTION OR FOR THE USE OF ANY PERSON IN CONNECTION WITH THE PREPARATION OF ANY TAX RETURN.  ACCORDINGLY, THIS ADVICE IS NOT INTENDED OR WRITTEN TO BE USED, AND IT CANNOT BE USED, BY ANY PERSON FOR THE PURPOSE OF AVOIDING TAX PENALTIES THAT MAY BE IMPOSED ON SUCH PERSON.

   

  15

  

   

  IN WITNESS WHEREOF, the parties have executed this Agreement on the Effective Date written above. 

    

  									
	 
	 
	 
	 
	 
	 
	 
	 
	 

	Syndax Pharmaceuticals, Inc.
	  
	 
	  
	 
	  
	EXECUTIVE

	 
	 
	 
	 
	 

	 
By:
	  
	 
/s/ Luke J. Albrecht
	  
	 
	  
	  
	By: 
	 
/s/ Steve M. Sabus

	 
	  
	 
	  
	 
	  
	 
	  
	 

    

  									
	 
	 
	 
	 
	 
	 
	 
	 
	 

	Name:
	  
	Luke J. Albrecht
	  
	 
	  
	 
	Name: 
	Steve M. Sabus

	Title:
	 
	General Counsel
	 
	 
	 
	 
	 
	 

	 
	 
	 
	 
	 
	 
	 
	 

    

  Exhibit A:	Release (Individual Termination – Age 40 or Older) 

  Exhibit B:	Release (Individual and Group Termination – Under Age 40) 

  Exhibit C:	Release (Group Termination – Age 40 or Older) 

   

  16

  

   

  EXHIBIT A

   

  RELEASE

  (INDIVIDUAL TERMINATION – AGE 40 OR OLDER)

  Certain capitalized terms used in this Release are defined in the Executive Employment Agreement (the “Agreement”) which I have executed and of which this Release is a part. 

  I hereby confirm my obligations under the Confidentiality Agreement (or other comparable agreement that I have signed, if any).

  Except as otherwise set forth in this Release, I hereby release, acquit and forever discharge the Company, its parents and subsidiaries, and their officers, directors, agents, servants, employees, shareholders, successors, assigns and affiliates, of and from any and all claims, liabilities, demands, causes of action, costs, expenses, attorneys’ fees, damages, indemnities and obligations of every kind and nature, in law, equity or otherwise, known and unknown, suspected and unsuspected, disclosed and undisclosed (other than any claim for indemnification I may have as a result of any third party action against me based on my employment with the Company), arising out of or in any way related to agreements, events, acts or conduct at any time prior to the date I execute this Release, including, but not limited to: all such claims and demands directly or indirectly arising out of or in any way connected with my employment with the Company or the termination of that employment, including, but not limited to, claims of intentional and negligent infliction of emotional distress, any and all tort claims for personal injury, claims or demands related to salary, bonuses, commissions, stock, stock options, or any other ownership interests in the Company, vacation pay, fringe benefits, expense reimbursements, severance pay, or any other form of compensation; and claims pursuant to any federal, state or local law or cause of action including, but not limited to, the federal Civil Rights Act of 1964, as amended, the federal Age Discrimination in Employment Act of 1967, as amended (“ADEA”), the federal Employee Retirement Income Security Act of 1974, as amended, the federal Americans with Disabilities Act of 1990, the California Fair Employment and Housing Act, as amended, the New York City Human Rights Law, as amended, the Massachusetts Fair Employment Practices Law, as amended, the South Carolina Human Affairs Law, as amended, tort law, contract law, wrongful discharge, discrimination, fraud, defamation, emotional distress, and breach of the implied covenant of good faith and fair dealing; provided, however, that nothing in this paragraph shall be construed in any way to (1) release the Company from its obligation to indemnify me pursuant to the Company’s indemnification obligation pursuant to written agreement or applicable law; (2) release any claim by me against the Company relating to the validity or enforceability of this release or the Agreement; (3) prohibit me from exercising any non-waivable right to file a charge with the United States Equal Employment Opportunity Commission (“EEOC”), the National Labor Relations Board (“NLRB”), or any other government agency (provided, however, that I shall not be entitled to recover any monetary damages or to obtain non-monetary relief if the agency were to pursue any claims relating to my employment with the Company). 

  I acknowledge that I am knowingly and voluntarily waiving and releasing any rights I may have to assert claims for age discrimination under applicable law, including under the ADEA.  I also acknowledge that the consideration given under the Agreement for the waiver and release in the preceding paragraph hereof is in addition to anything of value to which I was already entitled.  I further acknowledge that I have been advised by this writing, as required by the ADEA, that: (A) my waiver and release do not apply to any rights or claims that may arise on or after the date I execute this Release; (B) I have the right to consult with an attorney prior to executing this Release; (C) I have twenty-one (21) days to consider this Release (although I may choose to voluntarily execute this Release earlier); (D) I have seven (7) days following my execution of this Release to revoke the Release by providing a written notice of revocation to the 

  A-1 

  

   

  Company’s Chief Executive Officer; and (E) this Release shall not be effective until the date upon which the revocation period has expired, which shall be the eighth (8th) day after I execute this Release (provided that I do not revoke it). 

  I hereby represent that I have been paid all compensation owed and for all hours worked, I have received all the leave and leave benefits and protections for which I am eligible, pursuant to the federal Family and Medical Leave Act, any Company policy or applicable law, and I have not suffered any on-the-job injury or illness for which I have not already filed a workers’ compensation claim. 

  I agree that I will not make any disparaging statements regarding the Company or its officers, directors, shareholders, members, agents or products jointly or severally.  The foregoing shall not be violated by truthful statements in response to legal process, required governmental testimony or filings, or administrative or arbitral proceedings (including, without limitation, depositions in connection with such proceedings).  

   

   

  EXECUTIVE:

   

  						 

  Signature

   

  						 

  Printed Name

   

   

  Date: 						

   

   

   

   

  A-2 

  

   

  EXHIBIT B

  RELEASE

  (INDIVIDUAL AND GROUP TERMINATION – UNDER AGE 40)

  Certain capitalized terms used in this Release are defined in the Executive Employment Agreement (the “Agreement”) which I have executed and of which this Release is a part. 

  I hereby confirm my obligations under the Confidentiality Agreement (or other comparable agreement that I have signed, if any).

  Except as otherwise set forth in this Release, I hereby release, acquit and forever discharge the Company, its parents and subsidiaries, and their officers, directors, agents, servants, employees, shareholders, successors, assigns and affiliates, of and from any and all claims, liabilities, demands, causes of action, costs, expenses, attorneys’ fees, damages, indemnities and obligations of every kind and nature, in law, equity or otherwise, known and unknown, suspected and unsuspected, disclosed and undisclosed (other than any claim for indemnification I may have as a result of any third party action against me based on my employment with the Company), arising out of or in any way related to agreements, events, acts or conduct at any time prior to the date I execute this Release, including, but not limited to: all such claims and demands directly or indirectly arising out of or in any way connected with my employment with the Company or the termination of that employment, including, but not limited to, claims of intentional and negligent infliction of emotional distress, any and all tort claims for personal injury, claims or demands related to salary, bonuses, commissions, stock, stock options, or any other ownership interests in the Company, vacation pay, fringe benefits, expense reimbursements, severance pay, or any other form of compensation; and claims pursuant to any federal, state or local law or cause of action including, but not limited to, the federal Civil Rights Act of 1964, as amended, the federal Employee Retirement Income Security Act of 1974, as amended, the federal Americans with Disabilities Act of 1990, the California Fair Employment and Housing Act, as amended, the New York City Human Rights Law, as amended, the Massachusetts Fair Employment Practices Law, as amended, the South Carolina Human Affairs Law, as amended, tort law, contract law, wrongful discharge, discrimination, fraud, defamation, emotional distress, and breach of the implied covenant of good faith and fair dealing; provided, however, that nothing in this paragraph shall be construed in any way to  (1) release the Company from its obligation to indemnify me pursuant to the Company’s indemnification obligation pursuant to written agreement or applicable law; (2) release any claim by me against the Company relating to the validity or enforceability of this release or the Agreement; (3) prohibit me from exercising any non-waivable right to file a charge with the United States Equal Employment Opportunity Commission (“EEOC”), the National Labor Relations Board (“NLRB”), or any other government agency (provided, however, that I shall not be entitled to recover any monetary damages or to obtain non-monetary relief if the agency were to pursue any claims relating to my employment with the Company).

  I acknowledge that the consideration given under the Agreement for the waiver and release in the preceding paragraph hereof is in addition to anything of value to which I was already entitled.  I further acknowledge that I have been advised by this writing that: (A) my waiver and release do not apply to any rights or claims that may arise on or after the date I execute this Release; (B) I have the right to consult with an attorney prior to executing this Release; and (C) I have twenty-one (21) days to consider this Release (although I may choose to voluntarily execute this Release earlier). 

  I hereby represent that I have been paid all compensation owed and for all hours worked, I have received all the leave and leave benefits and protections for which I am eligible, pursuant to the federal Family and Medical Leave Act, any Company policy or applicable law, and I have not suffered any on-the-job injury or illness for which I have not already filed a workers’ compensation claim. 

  B-1 

  

   

  I agree that I will not make any disparaging statements regarding the Company or its officers, directors, shareholders, members, agents or products jointly or severally.  The foregoing shall not be violated by truthful statements in response to legal process, required governmental testimony or filings, or administrative or arbitral proceedings (including, without limitation, depositions in connection with such proceedings).  

    

   

  EXECUTIVE:

   

  						 

  Signature

   

  						 

  Printed Name

   

   

  Date: 						

   

   

  B-2 

  

   

  EXHIBIT C

   

  RELEASE

  (GROUP TERMINATION – AGE 40 OR OLDER)

  Certain capitalized terms used in this Release are defined in the Executive Employment Agreement (the “Agreement”) which I have executed and of which this Release is a part. 

  I hereby confirm my obligations under the Confidentiality Agreement (or other comparable agreement that I have signed, if any). 

  Except as otherwise set forth in this Release, I hereby release, acquit and forever discharge the Company, its parents and subsidiaries, and their officers, directors, agents, servants, employees, shareholders, successors, assigns and affiliates, of and from any and all claims, liabilities, demands, causes of action, costs, expenses, attorneys’ fees, damages, indemnities and obligations of every kind and nature, in law, equity or otherwise, known and unknown, suspected and unsuspected, disclosed and undisclosed (other than any claim for indemnification I may have as a result of any third party action against me based on my employment with the Company), arising out of or in any way related to agreements, events, acts or conduct at any time prior to the date I execute this Release, including, but not limited to: all such claims and demands directly or indirectly arising out of or in any way connected with my employment with the Company or the termination of that employment, including, but not limited to, claims of intentional and negligent infliction of emotional distress, any and all tort claims for personal injury, claims or demands related to salary, bonuses, commissions, stock, stock options, or any other ownership interests in the Company, vacation pay, fringe benefits, expense reimbursements, severance pay, or any other form of compensation; and claims pursuant to any federal, state or local law or cause of action including, but not limited to, the federal Civil Rights Act of 1964, as amended, the federal Age Discrimination in Employment Act of 1967, as amended (“ADEA”), the federal Employee Retirement Income Security Act of 1974, as amended, the federal Americans with Disabilities Act of 1990, the California Fair Employment and Housing Act, as amended, the New York City Human Rights Law, as amended, the Massachusetts Fair Employment Practices Law, as amended, the South Carolina Human Affairs Law, as amended, tort law, contract law, wrongful discharge, discrimination, fraud, defamation, emotional distress, and breach of the implied covenant of good faith and fair dealing; provided, however, that nothing in this paragraph shall be construed in any way to (1) release the Company from its obligation to indemnify me pursuant to the Company’s indemnification obligation pursuant to written agreement or applicable law; (2) release any claim by me against the Company relating to the validity or enforceability of this release or the Agreement; (3) prohibit me from exercising any non-waivable right to file a charge with the United States Equal Employment Opportunity Commission (“EEOC”), the National Labor Relations Board (“NLRB”), or any other government agency (provided, however, that I shall not be entitled to recover any monetary damages or to obtain non-monetary relief if the agency were to pursue any claims relating to my employment with the Company). 

  I acknowledge that I am knowingly and voluntarily waiving and releasing any rights I may have to assert claims for age discrimination under applicable law, including under the ADEA.  I also acknowledge that the consideration given under the Agreement for the waiver and release in the preceding paragraph hereof is in addition to anything of value to which I was already entitled.  I further acknowledge that I have been advised by this writing, as required by the ADEA, that: (A) my waiver and release do not apply to any rights or claims that may arise on or after the date I execute this Release; (B) I have the right to consult with an attorney prior to executing this Release; (C) I have forty-five (45) days to consider this Release (although I may choose to voluntarily execute this Release earlier); (D) I have seven (7) days following my execution of this Release to revoke the Release by providing a written notice of revocation to the Company’s Chief 

  C-1 

  

   

  Executive Officer; (E) this Release shall not be effective until the date upon which the revocation period has expired, which shall be the eighth day (8th) after I execute this Release; and (F) I have received with this Release the required written disclosure for a “group termination” under the ADEA, including a detailed list of the job titles and ages of all employees who were terminated in this group termination and the ages of all employees of the Company in the same job classification or organizational unit who were not terminated. 

  I hereby represent that I have been paid all compensation owed and for all hours worked, I have received all the leave and leave benefits and protections for which I am eligible, pursuant to the federal Family and Medical Leave Act, any Company policy or applicable law, and I have not suffered any on-the-job injury or illness for which I have not already filed a workers’ compensation claim. 

   

  I agree that I will not engage in any conduct that is injurious to the reputation of the Company or its parents, subsidiaries and affiliates, including but not limited to disparagement of the Company, its officers, Board members, employees and shareholders.  The foregoing shall not be violated by a statement made in a deposition, trial or administrative proceeding in response to legal process; by any statement made to a government agency; or whenever I make any statement to a court, administrative tribunal or government agency as required by law. 

   

  EXECUTIVE:

   

  						 

  Signature

   

  						 

  Printed Name

   

   

  Date: 						

   

  C-2Exhibit 10.8

 

EMPLOYMENT AGREEMENT

 

This Employment Agreement
(this “Agreement”) is entered into as of [____] (the “Effective Date”) by and between Nava Health
MD, LLC (the “Company” or “Nava”) and [__________] (the “Executive”).

 

WITNESSETH:

 

WHEREAS, the Company desires
the employment of the Executive in accordance with the provisions of this Agreement; and

 

WHEREAS, the Executive desires
and is willing to be employed by the Company in accordance with the provisions of this Agreement.

 

NOW THEREFORE, in consideration
of the premises and mutual covenants contained herein, and intending to be legally bound, the parties agree as follows:

 

1.                 
Employment.

 

(a)              
Position. On the terms and subject to the conditions set forth in this Agreement, the Company shall employ the Executive
and the Executive shall serve the Company as [_______________________].

 

(b)              
Duties. The Executive’s duties shall be prescribed from time to time by the [_______________] of the Company and shall
include such responsibilities as are customary for employees performing functions similar to those of the Executive. The Executive shall
devote substantially all of the Executive’s time and attention to the performance of the Executive’s duties and responsibilities
for and on behalf of the Company except as set forth herein or as may be consented to by the Company.

 

(c)              
Outside Activities. Notwithstanding anything to the contrary herein, Executive shall be permitted: (i) to serve as a member
of the board of directors or advisory board (or their equivalents in the case of a non-corporate entity) of any charitable or philanthropic
organization; (ii) to engage in charitable, community or philanthropic activities or any other activities; or (iii) to serve as an executor,
trustee or in a similar fiduciary capacity; provided, that the activities set out in the foregoing clauses shall be limited by
the Executive so as not to affect, interfere or conflict with, individually or in the aggregate, the performance of the Executive's duties
and responsibilities. Any outside activities in excess of the foregoing shall require the consent of the [________________], whose consent
will not be unreasonably withheld, delayed or conditioned.

 

(d)              
Company Policies. The employment relationship between the parties shall also be subject to the Company’s personnel
policies and procedures as they may be interpreted, adopted, revised or deleted from time to time in the Company’s sole discretion.
Notwithstanding the foregoing, in the event that the terms of this Agreement are in conflict with the Company’s general employment
policies or practices, this Agreement shall control.

 

    1

     

    

 

2.                 
 Term. This agreement shall remain in effect for two (2) years following the Effective Date unless sooner terminated in
accordance with Section 4. The period of time during which this Agreement remains in effect shall be referred to as the “Term.”
The parties expressly agree that designation of a Term does not in any way limit the right of the parties to terminate the Executive’s
employment at any time as hereinafter provided.

 

3.                 
Compensation. The Executive shall receive, for all services rendered to the Company pursuant to this Agreement, the following:

 

(a)       
Base Salary. The Employee shall be paid a base salary at the rate of [___________________________] per annum (the “Base
Salary”), less deductions for withholding taxes required under applicable law or as otherwise authorized by the Executive. The
Base Salary shall accrue from and after the Effective Date and shall be payable during the Term in equal periodic installments in accordance
with Company’s then current, general salary payment policies. The Executive’s Base Salary shall be reviewed periodically by
the [______________] and may be increased based upon the evaluation of the Executive’s performance and the compensation policies
of the Company in effect at the time of each such review.

 

(b)       Annual
Bonus. If Executive is employed by Nava through the last day of a calendar year during the Term, he/she may be entitled to receive
from Nava an amount up to [__]% of his/her Base Salary (“Annual Bonus”). The amount of the Annual Bonus, if any, shall be
determined by the Manager and be based on his/her annual performance review, Nava’s financial condition, and other annual performance
criteria established by the Manager in consultation with the Executive.

 

(c)       Equity
Compensation Plan. The Executive will be eligible to participate in any equity compensation plan established by Nava, subject to the
terms thereof, and to the extent that any discretionary awards are made thereunder by the Manager.

 

(d)       Benefits.

 

During the Term, the Company
shall provide the Executive with the following benefits:

 

(i)                
Group Health Plan. The Executive and his/her spouse shall be covered, if and to the extent eligible thereunder, by the group
health plan maintained by the Company (the “Group Health Plan”). During the Term, but only if the Group Health Plan
is fully insured, Nava shall pay the full cost of premiums for such coverage for the Executive and his/her spouse;

 

(ii)       Life
Insurance. Executive will be entitled to life insurance coverage in an amount equal to two (2) times his/her Base Salary under Nava’s
group term life insurance policy;

 

(iii)       LTD
Insurance. Nava will reimburse the Executive for the cost of purchasing long-term disability insurance under the terms of any policy
in effect as of the date hereof or another policy mutually agreeable to the Executive and Nava;

 

(e)       Condition
of Coverage. Nothing contained in this Agreement shall require Nava to establish, maintain, or continue any group health or life
insurance plan or restrict the right of Nava to amend, modify or terminate any such plan in a manner that does not discriminate
against the Executive as compared to other employees of Nava. If Nava cannot obtain the life and/or long-term disability insurance
coverage contemplated under Section 3(d) at standard rates under the terms of such insurance policies, then Nava will pay the
Executive the standard monthly premium in lieu of providing such coverage.

 

    2

     

    

 

(f)       Paid
Time Off. During the Term, the Executive shall be entitled to paid vacation, paid holidays and other paid time off (“PTO”)
for which executives of the Company are generally eligible, in each case consistent with Company policy in effect from time to time, but
not less than 25 days of PTO per calendar year during the Term. The Executive shall not be entitled to payment for unused PTO upon termination
of employment.

 

(g)       Withholding.
The Company is authorized to deduct and withhold from the Executive’s compensation all sums authorized by the Executive or necessary
or required (whether by law, court decree, executive order or otherwise), including, but not limited to, social security, income tax withholding
and otherwise, and any other amounts required by law or any taxing authority.

 

(h)       Expenses.
The Company shall reimburse the Executive for all reasonable out-of-pocket expenses incurred by the Executive in connection with the performance
of the Executive's duties and responsibilities hereunder upon presentment of a valid receipt or other usual and customary documents evidencing
such expenses. The Company will reimburse properly substantiated and timely submitted expenses no later than 30 days after the date that
the appropriate documentation is submitted by the Executive.

 

4.                 
Termination.

 

(a)              
Termination by the Executive For Any Reason, or by the Company With Cause. The employment of the Executive hereunder (and this
Agreement) may be terminated at any time by the Executive for any reason, or by the Company with Cause, in which event the Executive will
be entitled to the Standard Termination Benefits (as defined in Section 4(d)).

 

(b)       Termination
Due to Death or Disability of the Executive. The employment of the Executive hereunder (and this Agreement) shall terminate upon the
death or Disability of the Executive in which case Executive (or his/her estate, if applicable) will be entitled to the Standard Termination
Benefits (as defined in Section 4(d)). Executive (or his/her estate, if applicable) will also be entitled to the Severance Benefits
(as defined in Section 4(e)) in the event of termination due to death or Disability, subject to execution by the Executive of a
Release as described in Section 4(c) in the event of termination due to Disability. For purposes of this Agreement, “Disability”
shall mean a determination by the Manager that, because of a medically determinable disease, condition, injury or other physical or mental
disability, the Executive is unable to substantially perform his or her duties required hereby, and that such disability is determined
or reasonably expected to last for a continuous period of one hundred eighty (180) days (this definition to be interpreted and applied
consistently with the Americans with Disabilities Act, the Family and Medical Leave Act, and other applicable law).

 

(c)       Termination
by the Company without Cause. The employment of the Executive hereunder (and this Agreement) may be terminated at any time, at
the option of the Company without Cause. Termination by the Company without Cause shall be effective immediately after the Company
gives notice to Executive of Executive’s termination, unless the Company specifies a later date, in which case, termination
shall be effective as of such later date. If the Company terminates the Executive’s employment with the Company without Cause
as specified in the previous sentence, the Company shall pay to the Executive the Standard Termination Benefits. Additionally, if:
(i) the Executive delivers to the Company an effective, general release of claims in favor of the Company in a form substantially
similar to Exhibit A (the “Release”) within forty-five (45) days following the termination date; and (ii)
the Executive returns all Company property, complies in all material respects with his or her post-termination obligations under
this Agreement and the Release, and complies in all material respects with the Release including, without limitation, any
non-disparagement and confidentiality provisions contained therein, then the Executive shall receive the Severance Benefits.

 

    3

     

    

 

For purposes of this Agreement,
 “Cause” means: (i) an act of personal dishonesty in connection with the Executive’s responsibilities as an employee
of the Company that is intended to result in personal enrichment of the Executive; (ii) a plea of guilty or nolo contendere to, conviction
of, or an indictment for a felony or other crime involving theft, fraud, or moral turpitude in each case that the Manager reasonably believes
has had or will have a material detrimental effect on the Company’s reputation or business; (iii) a breach by the Executive of any
fiduciary duty owed to the Company that has, or is reasonably expected to have, a material detrimental effect on the Company’s reputation
or business as determined in good faith by the Manager; (iv) serious neglect or misconduct in the performance of Executive’s duties
for the Company; (v) willful or repeated failure or refusal to perform such duties if such failure continues uncured for ten (10) days
after written notice from the Manager(s) specifying in reasonable detail such failure; (vi) the material breach by the Executive of any
provision of Section 6 (Restrictive Covenants) hereof if (in the event such failure is reasonably susceptible of cure) such failure
continues uncured for ten (10) days after written notice from the Manager specifying in reasonable detail such failure; or (vii) the abuse
by the Executive of drugs or alcohol, if such abuse has or is reasonably expected to have a material adverse effect on the business of
the Company.

 

(d)       Standard
Termination Benefits in the Event of Separation from Employment. In the event that the Executive separates from employment for any
reason or no reason, the Company shall pay to the Executive within thirty (30) days of such termination: (i) accrued and unpaid Base Salary
in accordance with Section 3(a); (ii) any unreimbursed expenses payable in accordance with Section 3(e); and (iii) any amounts
payable under any of the benefit plans of the Company in which the Executive was a participant in accordance with applicable law and the
terms of those plans (collectively, the “Standard Termination Benefits”).

 

(e)       Severance.
Subject to Section 4(c), if the Company terminates the Executive’s employment at any time without Cause, or if the
Executive’s employment ends due to death or Disability, the Executive shall receive an amount equal to the Executive’s
then current Base Salary for twelve (12) months (the “Severance Period”), less all applicable withholdings and
deductions, paid in accordance with the Company’s standard payroll practices (subject to the provisions of this Section
4(e)), (the “Severance Benefits”). No payments of Severance Benefits will be made prior to the sixtieth
(60th) day following the Executive’s Separation from Service (as defined in Section 7(a)). On the 60th day following
the Executive’s Separation from Service (or within three business days thereafter), the Company will pay the Executive in a
lump sum the payments that the Executive would have received on or prior to such 60th day under the original schedule but
for the delay and with the balance of the payments being paid as originally scheduled. Moreover, if applicable, payments under this Section
4(e) shall be further delayed as described in Section 6(b).

 

    4

     

    

 

5.                 
Assignment of Intellectual Property Rights; Restrictive Covenants. In consideration of the Executive’s employment,
the Executive agrees to be bound by this Section 5.(a)General. The Executive agrees to assign, and hereby assigns, to the Company all
of his or her rights, title, and interest throughout the world in and to any Invention (as hereinafter defined) (including all Intellectual
Property Rights (as hereinafter defined) therein or related thereto) that were previously or are made, conceived or reduced to practice,
in whole or in part and whether alone or with others, by him or her during his or her employment by, or service with, the Company or
that arise out of any activity conducted by, for, or under the direction of the Company (whether or not conducted at the Company's facilities,
working hours, or using any of the Company’s assets) or that are useful with, or relate directly or indirectly to, any Company
Interest (as defined below). The Executive will promptly and fully disclose and provide all of the Inventions described above (the “Assigned
Inventions”) to the Company.

 

(b)             
Assurances. The Executive hereby agrees, during the Term and thereafter, to further assist the Company, at the Company’s
expense, to evidence, record and perfect the Company’s rights in and ownership of the Assigned Inventions, to perfect, obtain, maintain,
enforce and defend any rights specified to be so owned or assigned and to provide and execute all documentation necessary to effect the
foregoing, including the disclosure to the Company or its designee of all pertinent information and data with respect thereto, the execution
of all applications, specifications, oaths, assignments, recordations, and all other instruments that the Company or its designee shall
deem necessary in order to apply for, obtain, maintain and transfer such rights, or if not transferable, waive and agree never to assert
such rights, and in order to assign and convey to the Company or its designee, and any successors, assigns and nominees the sole and exclusive
right, title and interest in and to such Assigned Inventions, and any copyrights, patents, mask work rights or other intellectual property
rights relating thereto. Executive further agrees that his or her obligation to execute or cause to be executed any such instrument or
papers shall continue during and at all times after the end of the Term and until the expiration of the last such intellectual property
right to expire in any country of the world. Executive hereby irrevocably designates and appoints the Company and its duly authorized
officers and agents as his or her agent and attorney-in-fact to act for and in his or her behalf and stead to execute and file any such
instruments and papers and to do all other lawfully permitted acts to further the application for, prosecution, issuance, maintenance
or transfer of letters patent, copyright, mask work and other registrations related to such Assigned Inventions. This power of attorney
is coupled with an interest and shall not be affected by Executive’s subsequent incapacity.

 

(c)              
Other Inventions. The Executive agrees to not incorporate, or permit to be incorporated, any Invention conceived, created,
developed or reduced to practice by him or her (alone or with others) prior to or independently of his or her employment by the Company
or any of its subsidiaries (collectively, “Prior Inventions” disclosed on Exhibit B attached hereto) in any work he or she
performs for the Company without the Company’s prior written consent. If (i) he or she uses or discloses any Prior Inventions when
acting within the scope of his or her employment (or otherwise on behalf of the Company); or (ii) any Assigned Invention cannot be fully
made, used, reproduced or otherwise exploited without using or violating any Prior Inventions, the Executive hereby grants and agrees
to grant to the Company a perpetual, irrevocable, worldwide, royalty-free, non-exclusive, sublicensable right and license to reproduce,
make derivative works of, distribute, publicly perform, publicly display, make, have made, use, sell, import, offer for sale, and otherwise
exploit and exercise all such Prior Inventions and Intellectual Property Rights therein.

 

    5

     

    

 

(d)              
Definitions. “Company Interest” means any business of the Company or any product, service, Invention or Intellectual
Property Right that is used or under consideration or development by the Company. “Intellectual Property Rights” means any
and all intellectual property rights and other similar proprietary rights in any jurisdiction, whether registered or unregistered, and
whether owned or held for use under license with any third party, including all rights and interests pertaining to or deriving from: (a)
patents and patent applications, reexaminations, extensions and counterparts claiming property therefrom; inventions, invention disclosures,
discoveries and improvements, whether or not patentable; (b) computer software and firmware, including data files, source code, object
code and software-related specifications and documentation; (c) works of authorship, whether or not copyrightable; (d) trade secrets (including
those trade secrets defined in the Uniform Trade Secrets Act and under corresponding statutory law and common law), business, technical
and know-how information, non-public information, and confidential information and rights to limit the use of disclosure thereof by any
person; (e) trademarks, trade names, service marks, certification marks, service names, brands, trade dress and logos and the goodwill
associated therewith; (f) proprietary databases and data compilations and all documentation relating to the foregoing, including manuals,
memoranda, and record; (g) domain names; and (h) licenses of any of the foregoing, including in each case any registrations of, applications
to register, and renewals and extensions of, any of the foregoing with or by any governmental authority in any jurisdiction. “Invention”
means any products, processes, ideas, improvements, discoveries, developments, methods, techniques, know how, inventions, designs, algorithms,
financial models, formulas, writings, works of authorship, content, graphics, data, software, specifications, instructions, text, images,
photographs, illustration, audio clips, trade secrets and other works, material and information, tangible or intangible, whether or not
it may be patented, copyrighted or otherwise protected (including all versions, modifications, enhancements and derivative work thereof).

 

(e)       Restrictive
Covenants. The Executive agrees to be bound by the provisions of Exhibit C, which are incorporated herein by reference.

 

6.                 
Sections 409A of the Internal Revenue Code.

 

(a)       Separation
from Service. Notwithstanding anything in this Agreement to the contrary, to the extent that any severance or other payments or
benefits paid or provided to Executive, if any, under this Agreement are considered deferred compensation subject to Section
409A of the Code and the final regulations and any guidance promulgated thereunder (“Section 409A”) (such
payments, the “Deferred Payments”), then to the extent required by Section 409A, no Deferred Payments will be
payable unless Executive’s termination of employment also constitutes a “separation from service,” as defined in
Treasury Regulations Section 1.409A-1(h) (a “Separation from Service”). Similarly, no Deferred Payments payable
to Executive, if any, under this Agreement that otherwise would be exempt from Section 409A pursuant to Treasury Regulations Section
1.409A-1(b)(9) will be payable until Executive has a Separation from Service. For clarity, if Executive’s employment with
the Company is terminated by Executive or the Company (including, without limitation, by resignation) in a manner entitling
Executive to Severance Benefits, but the Executive does not incur a Separation from Service, then any severance payments or benefits
that are Deferred Payments and that are not immediately payable under this Section 7(a) will instead be paid to Executive
when Executive incurs a Separation from Service as if termination of employment occurred on such date notwithstanding that Executive
may no longer be employed under this Agreement.

 

    6

     

    

 

(b)       Payment
Delay. If, at the time of Executive’s Separation from Service, the Company determines that Executive is a “specified employee”
for purposes of Section 409A(a)(2)(B)(i) of the Code and that delayed commencement of any portion of the Deferred Payments is required
to avoid a prohibited distribution under Section 409A(a)(2)(B)(i) of the Code (any such delayed commencement, a “Payment
Delay”), then that portion of the Deferred Payments will not be provided to Executive until the earlier of (i) the expiration of
the six-month period measured from the date of Executive’s Separation from Service; (ii) the date of Executive’s death; or
(iii) such earlier date as is permitted under Section 409A. Upon the expiration of the applicable Code Section 409A(a)(2)(B)(i)
deferral period, all Deferred Payments deferred under the Payment Delay will be paid in a lump sum to Executive within 30 days following
such expiration, and any remaining payments due under this Agreement will be paid as otherwise provided in this Agreement. The determination
of whether Executive is a “specified employee” for purposes of Section 409A(a)(2)(B)(i) of the Code at the time of
Executive’s Separation from Service will be made by the Company, in its discretion, in accordance with Section 409A (including,
without limitation, Treasury Regulations Section 1.409A-1(i)). For purposes of Section 409A (including, without limitation,
for purposes of Treasury Regulations Section 1.409A-2(b)(2)(iii)), Executive’s right to receive the payments under this Agreement,
including the severance payments and benefits, will be treated as a right to receive a series of separate payments and, accordingly, each
installment payment will at all times be considered a separate and distinct payment.

 

(c)       Expense
Reimbursement. If required for compliance with Section 409A of the Code, any expenses incurred by Executive that are reimbursed
by the Company as a taxable reimbursement under this Agreement will be paid in accordance with Treasury Regulations Section 1.409A-3(i)(1)(iv)
and in accordance with the Company’s standard expense reimbursement policies, but in any event on or before the last day of Executive’s
taxable year following the taxable year in which Executive incurred the expenses. The amounts so reimbursed during any taxable year of
Executive will not affect the amounts provided in any other taxable year of Executive, and Executive’s right to reimbursement for
these amounts will not be subject to liquidation or exchange for any other benefit.

 

7.                 
Attorneys’ Fees. If any action at law or in equity (including arbitration) is necessary to enforce or interpret the
terms of any provision of this Agreement, the prevailing party shall be entitled to reasonable attorneys’ fees, costs and necessary
disbursements in addition to any other relief to which such party may be entitled pursuant to the underlying action.

 

8.                 
No Conflicts. The Executive represents and warrants to the Company that the execution, delivery and performance by the
Executive of this Agreement do not conflict with or result in a violation or breach of, or constitute (with or without the giving of
notice or the lapse of time or both) a default under any contract, agreement or understanding, whether oral or written, to which the
Executive is a party or by which the Executive is bound and that there are no restrictions, covenants, agreements or limitations on the
Executive’s right or ability to enter into and perform the terms of this Agreement, and the Executive agrees to indemnify and save
the Company harm from any liability, cost, or expense, including attorney's fees, based upon or arising out of any breach of this Section
8.

 

    7

     

    

 

9.                 
Waiver. The waiver by either party of any breach by the other party of any provision of this Agreement shall not operate
or be construed as a waiver of any subsequent breach by such party. No person acting other than pursuant to a resolution of the Company
shall have authority on behalf of the Company to agree to amend, modify, repeal, waive or extend any provision of this Agreement.

 

10.             
Successors and Assigns; Assignment. This Agreement shall be binding upon and inure to the benefit of the successors and
assigns of the Company. Upon conversion of the Company to corporate form, references in this Agreement to “Manager(s)” shall
be deemed to refer to the Board of Directors of the Company, except that, upon such conversion, references to the “Manager”
in Sections 3(b) and 3(c) herein shall be deemed to refer specifically to the Compensation Committee of the Board of Directors. This Agreement
shall inure to the benefit of and be enforceable by the Executive or his or her legal representatives, executors, administrators and heirs.
The Executive may not assign any of the Executive’s duties, responsibilities, obligations or positions hereunder to any person,
and any such purported assignment by the Executive shall be void and of no force and effect.

 

11.             
Notices. All notices, requests, demands, and other communications that are required or may be given pursuant to this Agreement
shall be in writing and shall be deemed to have been duly given when received if personally delivered, upon confirmation of transmission
if sent by telecopy, electronic, or digital transmission, the day after it is sent, if sent for next day delivery to a domestic address
by a recognized overnight delivery service (e.g., Federal Express), and upon receipt, if sent by certified or registered mail, return
receipt requested. In each case, notice shall be sent to:

 

If to Executive, addressed
to:

 

[________________]

 

If to the Company, addressed
to:

 

Nava Health MD, LLC

9755 Patuxent Woods Drive

Columbia, Maryland 21046

[______________]

 

or to such other place and with such other copies
as either party may designate as to itself by written notice to the others.

 

    8

     

    

 

12.             
 Miscellaneous.

 

(a)       Governing
Law; Jurisdiction/Venue. This Agreement shall be governed by, and its provisions construed and enforced in accordance with, the internal
laws of the State of Maryland without reference to its principles regarding conflicts of law. Both parties agree to submit to the exclusive
jurisdiction and venue of the state and federal courts located in the State of Maryland for any disputes arising out of this Agreement.

 

(b)       Waiver
of Jury Trial. The parties hereby waive their respective rights to a trial by jury and further agree that no demand, request or motion
will be made for trial by jury.

 

(c)       Severability.
In the event that any one or more of the provisions of this Agreement shall be held to be invalid, illegal or unenforceable, the validity,
legality or enforceability of the remaining provisions shall not in any way be affected or impaired thereby.

 

(d)       Headings.
The descriptive headings of the several paragraphs of this Agreement are inserted for convenience of reference only and shall not constitute
a part of this Agreement.

 

(e)       Entire
Agreement. This Agreement, inclusive of exhibits and schedules, contains the entire agreement of the parties concerning the Executive’s
employment and all promises, representations, understandings, arrangements and prior agreements on such subject are merged herein and
superseded hereby.

 

(f)       Representation
by Counsel. Each of the parties hereto acknowledges that: (i) it or he or she has read this Agreement in its entirety and understands
all of its terms and conditions; (ii) it or he or she has had the opportunity to consult with any individuals of its or his or her choice
regarding its or his or her agreement to the provisions contained herein, including legal counsel of its or his or her choice, and any
decision not to was its or his or her alone; and (iii) it or he or she is entering into this Agreement of its or his or her own free will,
without coercion from any source.

 

(g)       Survival.
The provisions of this Agreement that remain applicable following termination of employment shall survive termination of this Agreement.

 

(h)       Counterparts.
This Agreement may be executed in one or more counterparts, each of which shall be deemed an original, and all of which together shall
constitute one and the same Agreement. Delivery of facsimile or .pdf, or other electronic copies (complying with the U.S. federal ESIGN
Act of 2000 (e.g., www.docusign.com)) of signature pages for this Agreement shall be valid and treated for all purposes as delivery of
the originals.

 

[SIGNATURES ON FOLLOWING PAGE]

 

    9

     

    

 

IN WITNESS WHEREOF, the Company has caused this
Agreement to be executed by its duly authorized officer, and the Executive has set his or her hand, all effective as of the Effective
Date.

 

	 	NAVA
    HEALTH MD, LLC	 
	 	 	 
	 	By:	                                     	 
	 	 	 
	 	Name:	 	 
	 	 	 
	 	Title:	 	 
	 	 	 
	 	Date:	 	 
	 	 	 
	 	 	 
	 	EXECUTIVE	 
	 	 	 
	 	 	 
	 	[_________________]       	 
	 	 	 
	 	Date:	 	 

 

    10

     

    

 

EXHIBIT A

 

Release Agreement

 

This Release Agreement (“Release”)
is made by and between Nava Health MD, LLC (the “Company”) and [___________] (“you”). You and the Company entered
into an Executive Employment Agreement dated _______________ (the “Employment Agreement”). You and the Company hereby further
agree as follows:

 

1.       A
blank copy of this Release was attached to the Employment Agreement as Exhibit A.

 

2.       Severance
Payments. If your employment was terminated by the Company without Cause or due to your Disability (as defined in the Employment Agreement),
then in consideration for your execution, return, and non-revocation of this Release, following the Release Date (as defined in Section
3 below), the Company will provide the severance benefits set forth in your Employment Agreement.

 

3.       Release
by You. In exchange for the payments and other consideration under this Agreement, to which you would not otherwise be entitled, and except
as otherwise set forth in this Agreement, you hereby generally and completely release, acquit and forever discharge the Company, its respective
subsidiaries, affiliates, predecessors, current and former directors, members, officers, employees, agents, stockholders, heirs, beneficiaries,
its successors and assigns (both individually and in their official capacities), its parents and subsidiaries, and its officers, directors,
managers, partners, agents, servants, employees, attorneys, shareholders, successors, assigns and affiliates (the “Company Parties”)
of and from any and all claims, liabilities, demands, causes of action, costs, expenses, attorneys’ fees, damages, indemnities and
obligations of every kind and nature, in law, equity, or otherwise, both known and unknown, suspected and unsuspected, disclosed and undisclosed,
arising out of or in any way related to agreements, events, acts or conduct at any time prior to and including the execution date of this
Agreement, including but not limited to: all such claims and demands directly or indirectly arising out of or in any way connected with
your employment with the Company or the termination of that employment; claims or demands related to salary, bonuses, commissions, stock,
stock options, or any other ownership interests in the Company; vacation pay, fringe benefits, expense reimbursements, severance pay,
or any other form of compensation; claims pursuant to any federal, state or local law, statute, or cause of action; tort law; or contract
law. The claims and causes of action you are releasing and waiving in this Agreement include, but are not limited to, any and all claims
and causes of action that the Company Parties:

 

• have violated their
personnel policies, handbooks, contracts of employment, or covenants of good faith and fair dealing;

 

• have
discriminated, harassed, or retaliated against you on the basis of age, race, color, sex (including sexual harassment), national
origin, ancestry, disability, religion, sexual orientation, marital status, parental status, source of income, entitlement to
benefits, any union activities or other protected category in violation of any local, state or federal law, constitution, ordinance,
or regulation, including but not limited to: the Age Discrimination in Employment Act, as amended (“ADEA”); Title VII of
the Civil Rights Act of 1964, as amended; 42 U.S.C. § 1981, as amended; the Civil Rights Act of 1866; the Worker Adjustment
Retraining and Notification Act; the Equal Pay Act; the Americans With Disabilities Act; the Genetic Information Non-Discrimination
Act; the Family Medical Leave Act; the Occupational Safety and Health Act; the Immigration Reform and Control Act; the Uniform
Services Employment and Reemployment Rights Act of 1994, as amended; Section 510 of the Employee Retirement Income Security
Act; and the National Labor Relations Act;

 

    11

     

    

 

• have violated any
statute, public policy or common law (including but not limited to claims for retaliatory discharge; negligent hiring, retention or supervision;
defamation; intentional or negligent infliction of emotional distress and/or mental anguish; intentional interference with contract; negligence;
detrimental reliance; loss of consortium to you or any member of your family; and/or promissory estoppel).

 

Notwithstanding the foregoing, you are not releasing
any right of indemnification that you may have for any liabilities arising from your actions within the course and scope of your employment
with the Company or within the course and scope of your role as a member of the Board of Directors and/or officer of the Company (if applicable).
Also excluded from this Agreement are any claims that cannot be waived by law. You are waiving, however, your right to any monetary recovery
should any governmental agency or entity, such as the EEOC or the DOL, pursue any claims on your behalf. You acknowledge that you are
knowingly and voluntarily waiving and releasing any rights you may have under the ADEA, as amended. You also acknowledge that (i) the
consideration given to you in exchange for the waiver and release in this Agreement is in addition to anything of value to which you were
already entitled; and (ii) that you have been paid for all time worked, have received all the leave, leaves of absence, leave benefits
and protections for which you are eligible, and have not suffered any on-the-job injury for which you have not already filed a claim.
You further acknowledge that you have been advised by this writing that: (a) your waiver and release do not apply to any rights or claims
that may arise after the execution date of this Agreement; (b) you have been advised hereby that you have the right to consult with an
attorney prior to executing this Agreement; (c) you have twenty-one (21) days to consider this Agreement (though you may choose to voluntarily
execute this Agreement earlier); (d) you have seven (7) days following your execution of this Agreement to revoke the Agreement; and (e)
this Agreement shall not be effective until the date upon which the revocation period has expired unexercised, which shall be the eighth
day after this Agreement is executed by you provided the Company has also executed the Release on or before that date (the “Release
Date”).

 

4.       Return
of Company Property. Within ten (10) days of the effective date of the termination of employment, you agree to return to the Company
all Company documents (and all copies thereof) and other Company property then in existence that you have had in your possession at
any time, including, but not limited to, Company files, notes, drawings, records, business plans and forecasts, financial
information, specifications, computer-recorded information, tangible property (including, but not limited to, computers), credit
cards, entry cards, identification badges and keys; and, any materials of any kind that contain or embody any proprietary or
confidential information of the Company (and all reproductions thereof); provided, however, that you may retain copies of any
agreements by and between you and the Company, including, without limitation, your employment agreement, employee proprietary
information agreement, inventions, non-competition and non-solicitation agreement, side letter, promissory note, pledge agreement,
stock award agreement and other documents related to your equity to which you are a party. Receipt of the Severance described in
paragraph 2 of this Release is expressly conditioned upon return of all such Company property.

 

    12

     

    

 

5.       Confidentiality.
The provisions of this Release will be held in strictest confidence by you and the Company will not be publicized or disclosed in any
manner whatsoever; provided, however, that: (a) you may disclose this Agreement in confidence to your immediate family; (b) the parties
may disclose this Agreement in confidence to their attorney, accountant, auditor, tax preparer, and financial advisor; and (c) the parties
may disclose this Release insofar as such disclosure may be required by law.

 

6.       Proprietary
Information and Post-Termination Obligations. You acknowledge your surviving and continuing obligations under the Employment Agreement
not to use or disclose any confidential or proprietary information of the Company and its affiliates (as such term is defined in the Securities
Act of 1933, as amended) and to refrain from certain solicitation and competitive activities.

 

7.       Non-Disparagement.
You agree not to disparage the Company or its officers, directors, employees, shareholders, and agents in each case in any manner likely
to be harmful to them or their business, business reputation or personal reputation provided that you will respond accurately and fully
to any question, inquiry or request for information when required by legal process.

 

8.        Permissibility
of Disclosure. 18 U.S.C. § 1833(b) provides: “An individual shall not be held criminally or civilly liable under any Federal
or State trade secret law for the disclosure of a trade secret that—(A) is made—(i) in confidence to a Federal, State, or
local government official, either directly or indirectly, or to an attorney; and (ii) solely for the purpose of reporting or investigating
a suspected violation of law; or (B) is made in a complaint or other document filed in a lawsuit or other proceeding, if such filing is
made under seal.” Nothing in this Agreement is intended to conflict with 18 U.S.C. § 1833(b) or create liability for disclosures
of trade secrets that are expressly allowed by 18 U.S.C. § 1833(b). Accordingly, the parties to this Agreement have the right to
disclose in confidence trade secrets to federal, state, and local government officials, or to an attorney, for the sole purpose of reporting
or investigating a suspected violation of law. The parties also have the right to disclose trade secrets in a document filed in a lawsuit
or other proceeding, but only if the filing is made under seal and protected from public disclosure.

 

9.       No
Admission. This Agreement does not constitute an admission by you or the Company of any wrongful action or violation of any federal, state,
or local statute or common law rights, including those relating to the provisions of any law or statute concerning employment actions
or of any other possible or claimed violation of law or rights.

 

10.       Breach.
You agree that upon any material breach by you of this Release as determined by an arbitrator or court of competent jurisdiction,
you will forfeit all amounts paid or owing to you under this Release. The parties acknowledge that it may be impossible to assess
the damages caused by the other party’s material violation of the terms of paragraphs 4, 5, 6, and 7 of this Release and
further agree that any threatened or actual material violation or breach of those paragraphs of this Release will constitute
immediate and irreparable injury to the non-breaching party. The parties therefore agree that any such breach of those paragraphs of
this Release is a material breach of this Agreement, and in addition to any and all other damages and remedies available, the
non-breaching party shall be entitled to seek an injunction to prevent the other party from violating or breaching this
Agreement.

 

    13

     

    

 

11.       Miscellaneous.
This Release constitutes the complete, final and exclusive embodiment of the entire agreement between you and the Company with regard
to this subject matter. It is entered into without reliance on any promise or representation, written or oral, other than those expressly
contained herein and it supersedes any other such promises, warranties, or representations. This Release may not be modified or amended
except in a writing signed by both you and a duly authorized officer of the Company. This Release will bind the heirs, personal representatives,
successors and assigns of both you and the Company, and inure to the benefit of both you and the Company, their heirs, successors and
assigns. If any provision of this Release is determined to be invalid or unenforceable, in whole or in part, this determination will not
affect any other provision of this Release, and the provision in question will be modified by the court so as to be rendered enforceable.
This Release will be deemed to have been entered into and will be construed and enforced in accordance with the laws of the State of Maryland
as applied to contracts made and performed entirely within State of Maryland.

 

COMPANY

 

Nava Health MD, LLC

 

	By:	 	 	 
	 	[NAME AND TITLE]	 	Date

 

EXECUTIVE

 

	 	 	 
	[__________________]	 	Date

 

    14

     

    

 

EXHIBIT B

 

Prior Inventions

 

None

 

    15

     

    

 

EXHIBIT C

 

Restrictive Covenants

 

    16

     

    

 

NON-DISCLOSURE, NON-COMPETITION
AND

NON-SOLICITATION AGREEMENT

 

THIS NON-DISCLOSURE, NON-COMPETITION AND NON-SOLICITATION
AGREEMENT (herein “Agreement”) is hereby entered into this _____ day of __________, 2022, between __________ (herein “Employee”)
and NAVA Health MD, LLC (“the Company”), who are collectively referred to as the “Parties.” In consideration of
the value of employment or continued employment with the Company, the receipt and sufficiency of which is hereby acknowledged, and in
recognition of the Company’s legitimate purpose of protecting its Confidential Information, assets and goodwill, the Parties agree
as follows:

 

1.            Employee
will have access to and will acquire certain confidential and proprietary information about the business of the Company and its Affiliates
that is not available to the general public (“Confidential Information”) as a result of Employee’s job duties. This
Confidential Information may include, but is not limited to, information regarding the Company’s and its Affiliates’ trade
secrets, marketing efforts, methods of operation, business processes, patients and prospective patients, business partners, suppliers,
vendors, financial data, patient data, employee data, provider data, professional reimbursement data, managed care contracts, health care
provider agreements, and personnel data. The Confidential Information of the Company and its Affiliates is the exclusive property of the
Company. Employee agrees not to disclose, during or after employment with the Company, such Confidential Information to any person, firm,
corporation, association or other entity for any reason or purpose whatsoever. Employee also will not make use of any such Confidential
Information for Employee’s own purposes or for the benefit of any person, firm, corporation or other entity (except the Company
and/or its Affiliates) under any circumstances, during or after employment. The foregoing covenant against use and disclosure does not
apply to Confidential Information of the Company and/or its Affiliates which: (i) is or becomes generally available to the public
other than as a result of disclosure made, directly or indirectly, by Employee or as a result of any disclosure which, to Employee’s
knowledge, violates a legal or contractual non-disclosure obligation owed by a third party to the Company and/or its Affiliates; or (ii) was
or becomes available to Employee on a non-confidential basis from a source, other than the Company and/or its Affiliates or a party acting
on behalf of the Company, who is not legally or contractually bound to preserve the confidentiality of such information. For the purposes
of this Agreement, “Affiliate” means any person or entity that, directly or indirectly, is controlled by, or under common
control with the Company. Notwithstanding anything to the contrary in this Agreement, Employee’s continuing confidentiality obligations
under the Agreement do not prohibit him/her from disclosing Confidential Information to a federal, state or local government official
or to an attorney for the purpose of reporting or investigating a violation of law or in a court filing under seal. Accordingly, Employee
hereby acknowledges and understands that pursuant to the Federal Trade Secrets Act of 2016, he/she has advised that he/she has immunity
from being held criminally or civilly liable under any Federal or State trade secret law for the disclosure of a trade secret that (A) is
made (i) in confidence to a Federal, State, or local government official, either directly or indirectly, or to an attorney; and (ii) solely
for the purpose of reporting or investigating a suspected violation of law; or (B) is made in a complaint or other document filed
in a lawsuit or other proceeding, if such filing is made under seal.

 

    	 	17	 

     

    

 

2.            Upon
termination of employment with the Company, for any reason, Employee agrees to return immediately all Company property and documents including,
but not limited to, memoranda, books, papers, letters, manuals, and other data, and all hard or electronic copies thereof, in any way
relating to the business of the Company and its Affiliates.

 

3.            During
the course of employment, Employee may work on and become part of the development of technical or other systems for the Company. Employee
agrees that systems and information developed by Employee shall be, and will remain, the sole and absolute property of the Company.

 

4.            Employee
agrees that during employment and for a period of two (2) years after separation from employment, whether voluntary or involuntary
or with or without cause, Employee will not, on his/her own behalf or as a partner, officer, director, employee, agent, or consultant
of any other person or entity, directly or indirectly, engage or attempt to engage in the business of providing services the same as or
similar to the Company and/or its Affiliates within Virginia, Maryland, the District of Columbia in a capacity the same as or similar
to Employee’s capacity at the Company. Employee further agrees that during employment and for a period of two (2) years after
separation from employment, whether voluntary or involuntary or with or without cause, Employee will not, on his/her own behalf or as
a partner, officer, director, employee, agent, or consultant of any other person or entity, directly or indirectly, engage or attempt
to engage in the business of providing services the same as or similar to the Company and/or its Affiliates within any city, county, or
state in which the Company or its affiliates is providing services to patients at the time of Employee’s separation from employment
in a capacity the same as or similar to Employee’s capacity at the Company.

 

5.            Employee
agrees that during employment and for a period of two years after separation from employment, whether voluntary or involuntary or with
or without cause, Employee will not whether for his/her own account or on behalf of any other person or entity, and whether acting as
an employee, agent, officer, stockholder, partner or owner of another person or entity or in some other capacity, in any manner hire an
Employee of the Company, solicit the employment of any Employee of the Company, in any manner encourage any Employee of the Company to
leave his/her employment with the Company, or cause an Employee of the Company to be solicited for hire, hired, or encouraged to leave
employment with the Company. For purposes of this paragraph, Employee of the Company means any individual who was employed by the Company
at the time of Employee’s separation from employment or within the six months prior to Employee’s separation from employment.
Employee of the Company does not include any individual who has not been employed by the Company for a period of at least six (6) months.

 

6.            Employee
agrees that during employment and for a period of two years after separation from employment, whether voluntary or involuntary or with
or without cause, Employee will not whether for his/her own account or on behalf of any other person or entity, and whether acting as
an employee, agent, officer, stockholder, partner or owner of another person or entity or in some other capacity, in any manner solicit
an individual who was a patient of the Company or its affiliates for the purposes of providing services the same as or similar to those
provided to such patient by the Company or in any manner encourage any patient of the Company or its affiliates to cease receiving services
from the Company or its affiliates. For purposes of this paragraph, patient of the Company means any individual who received wellness
services from the Company or its affiliates at the time of Employee’s separation from employment or within the six months prior
to Employee’s separation from employment. Employee of the Company does not include any individual who has not been employed by the
Company for a period of at least six (6) months

 

    	 	18	 

     

    

 

7.            Employee
agrees that, to the maximum extent permitted by law, he/she will not, by any verbal, written or electronic expression or communication,
or by any deed or act of communication, make knowingly false statements about the Company, its officers, agents, or employees, or their
reputation or character, or any of their actions, services, products, writings, policies, practices, procedures or advertisements.

 

8.            The
provisions of this Agreement shall be enforced to the fullest extent permissible under the laws and public policies applied in each jurisdiction
in which enforcement is sought. Accordingly, if any particular portion of this Agreement shall be adjudicated to be invalid or unenforceable,
such portion shall be deemed amended or deleted to the extent necessary to be valid and enforceable.

 

9.            The
prevailing party, after exhaustion of all appeals, in any action pursuant to this Agreement shall be entitled to the award of reasonable
attorneys’ fees and court costs.

 

10.          The
Parties agree that this Agreement shall be binding upon Employee and his/her heirs, successors, assigns, and personal representatives,
and inure to the benefit of the Company, its successors and its assigns. Employee may not assign any rights or duties under this Agreement.

 

11.          The
Parties agree that the failure of the Company to enforce any term of this Agreement (or any agreement with any other person) shall not
constitute a waiver of the Company’s rights or deprive the Company of the right to insist thereafter upon strict adherence to that
or any other term of this Agreement, nor shall a waiver of any breach of this Agreement constitute a waiver of any preceding or succeeding
breach, nor shall the passage of any amount of time after the Company becomes aware of a breach of this Agreement constitute a waiver
of the Company’s rights to enforcement.

 

12.          This
Agreement supersedes all prior agreements between the Parties concerning the subject matter hereof, and this Agreement constitutes the
entire agreement between the Parties with respect to the subject matter hereof and all previous discussions, promises, representations,
and understandings relating to the topics herein discussed are hereby merged into this Agreement. This Agreement may be modified only
by a written instrument signed by Employee and the Chief Executive Officer of the Company. No person has any authority to make any representation
or promise on behalf of any of the Parties not set forth herein, and this Agreement has not been executed in reliance upon any representation
or promise except those executed herein. Employee recognizes and acknowledges that this Agreement does not alter the terms and conditions
of Employee’s Employment Agreement with the Company except as it relates to Employee’s non-competition, non-solicitation,
and non-disclosure obligations. All other terms and conditions of Employee’s Employment Agreement with the Company including, but
not limited to, Employee’s term of employment, notification of termination, and binding arbitration remain in full force and effect.

 

    	 	19	 

     

    

 

13.          The
validity and construction of this Agreement or of any of its terms or provisions shall be determined under the laws of the State of Maryland,
regardless of any principles of conflicts of laws or choice of laws of any jurisdiction. The state courts of the State of Maryland and,
if the jurisdictional prerequisites exist at the time, the United States District Court for the District of Maryland, shall have sole
and exclusive jurisdiction to hear and determine any dispute or controversy arising under or concerning this Agreement.

 

14.          Employee
acknowledges that he/she has read this Agreement in its entirety and understands all of its terms and conditions, that he/she has had
the opportunity to consult with any individuals of his/her choice regarding his/her agreement to the provisions contained herein, including
legal counsel of his/her choice, that he/she is entering into this Agreement of his/her own free will, without coercion from any source,
and he/she agrees to abide by all of the terms and conditions herein contained.

 

IN WITNESS WHEREOF, the parties have duly executed
this Agreement as of the day and year first above written.

 

		 	 
	[Employee Name]	 	 
	 	 	For: NAVA Health MD, LLC

 

    	 	20

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00351-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00351-of-00352.parquet"}]]